0001854587-24-000018 | 20-F | XBRL Viewer

Print Document View Excel Document

Shareholders’ equity (deficiency) - Narrative (Details)				12 Months Ended
Shareholders’ equity (deficiency) - Narrative (Details)	Aug. 30, 2021 $ / shares	Aug. 05, 2021 shares	Jun. 17, 2019 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) vote $ / shares shares	Dec. 31, 2022 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2023 ₪ / shares	Dec. 31, 2022 ₪ / shares shares
Class of Stock [Line Items]
Reverse stock split, conversion ratio	0.9595
Common stock, shares authorized (in shares)				3,454,112,863				3,454,112,863
Common stock par value per share (in NIS per share) \| (per share)	$ 10						₪ 0.00001	₪ 0.00001
Number of votes per share \| vote				1
Issuance of redeemable convertible preferred shares (in shares)			39,779,261
Temporary equity issued during period, price per share (in USD per share) \| $ / shares			$ 2.765
Stock issued during period, value of new issues \| $			$ 101,205,000
Proceeds from issuance of redeemable convertible preferred stock \| $			110,000,000
Employee compensation paid after the issuance of redeemable convertible preferred shares \| $			$ 4,034,000
Shares, options and RSUs outstanding (in shares)				23,888,325
Grants in period, weighted average grant date fair value (in USD per share) \| $ / shares				$ 3.59	$ 2.86	$ 5.04
Options, intrinsic value of exercises in period \| $				$ 33,237,000	$ 12,116,000	$ 8,547,000
Options outstanding (in shares)				15,728,176				20,457,660
Share-based payment arrangement, cost not yet recognized \| $				$ 52,917,000
Expected period for recognition				2 years 11 months 12 days
Granted (in shares)				3,222,786
The 2021 Plan
Class of Stock [Line Items]
Share-based compensation arrangement, shares authorized (in shares)		37,653,880
Granted (in shares)				12,435,797
Restricted Stock Units (RSUs)
Class of Stock [Line Items]
Grants in period, Weighted average grant date fair value (in USD per share) \| $ / shares				$ 5.75	$ 6.02	$ 8.27
Equity instruments other than options, vested in period, fair value \| $				$ 13,805,000	$ 3,025,000	$ 927,000
Options, in-the-money
Class of Stock [Line Items]
Options outstanding (in shares)				15,728,176,000		25,440,041,000		18,121,448,000
Options, out-of-the-money
Class of Stock [Line Items]
Options outstanding (in shares)						47,856		2,336,212
Options outstanding, aggregate intrinsic value \| $				$ 0
Employee Stock
Class of Stock [Line Items]
Share-based compensation arrangement, number of additional shares authorized (in shares)		1,871,687
Share-based compensation arrangement, annual allowable percent increase in number of shares authorized		1.00%
Cellebrite DI Ltd \| IGP Saferworld Limited Partnership
Class of Stock [Line Items]
Temporary equity, common and preferred share equivalent ownership percentage			24.40%

Revenues - Schedule of Contract Balances (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Contract with Customer, Liability, Current	$ 195,725	$ 152,709
Contract with Customer, Liability, Noncurrent	$ 47,098	$ 42,173

Property and equipment, net

12 Months Ended

Dec. 31, 2023

Property, Plant and Equipment [Abstract]

Property and equipment, net

Note 8. Property and equipment, net


	December 31, 2023		December 31, 2022

Manufacturing equipment	$	582	$	546
Furniture and equipment	10,461		10,203
Leasehold improvements	7,465		6,674
Computers and software	30,641		27,140
	49,149		44,563

Less—accumulated depreciation	(33,253)		(27,304)
	$	15,896	$	17,259

Depreciation expenses were $6,664, $6,368 and $5,036 in the year ended December 31, 2023, 2022 and 2021, respectively.

Intangible assets, net - Schedule of Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross amounts	$ 20,027	$ 17,340
Accumulated amortization	9,433	6,086
Intangible assets, net	10,594	11,254
Amortization expense	3,347	2,826	$ 1,971
Technology-Based Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Gross amounts	15,950	13,263
Accumulated amortization	5,657	3,303
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross amounts	3,900	3,900
Accumulated amortization	3,738	2,763
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross amounts	177	177
Accumulated amortization	$ 38	$ 20

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Property and Equipment

Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.


	December 31, 2023		December 31, 2022

Manufacturing equipment	$	582	$	546
Furniture and equipment	10,461		10,203
Leasehold improvements	7,465		6,674
Computers and software	30,641		27,140
	49,149		44,563

Less—accumulated depreciation	(33,253)		(27,304)
	$	15,896	$	17,259

Weighted-Average Assumptions For Options Granted to Employees and Non-Employees

The Company used the following weighted-average assumptions for options granted to employees and non-employees:


	Year ended December 31,
	2023	2022	2021
Contractual period in years	10	10	10
Volatility	50.3% - 51.8%	43.2% - 51.9%	35.9% - 52.7%
Risk free interest rate	3.7% - 4.5%	2.0% - 4.2%	1.3% - 1.4%
Dividend yield	0%	0%	0% - 5%
Exercise price	$4.95 - $7.99	$4.79 - $6.60	$5.41 - $8.27
Fair value of Ordinary Share	$4.95 - $7.99	$4.79 - $6.60	$5.41 - $8.27
Expected term	6.11	6.11	6.11

The fair value of ESPP was estimated on the grant date using Monte Carlo valuation methodology with the following weighted average assumptions:


						Year Ended December 31,
						2023

Volatility						39.7%-50.5%
Expected term						6 months
Risk-free interest rate						4.2%-5.1%
Share price						$4.69-$8.42
Dividend yield						0%

Schedule of Finite-Lived Intangible Assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Finite-lived intangible assets:


	December 31, 2023		December 31, 2022


Original amounts:
Core technology	$	15,950	$	13,263
Trade name	3,900		3,900
Customer relationship	177		177
	20,027		17,340
Accumulated amortization:
Core technology	5,657		3,303
Trade name	3,738		2,763
Customer relationship	38		20
	9,433		6,086
Intangible assets, net
	$	10,594	$	11,254

a. Amortization expense amounted to $3,347, $2,826 and $1,971 for the years ended December 31, 2023, 2022 and 2021, respectively.

Long-Lived Assets by Geographic Areas

The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets:


	December 31,
		2023		2022

EMEA		$	20,691	$	26,595
Americas		8,024		5,712
APAC		1,441		605
Total long-lived assets		$	30,156	$	32,912

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2023
Auditor Information [Abstract]
Auditor Firm ID	1281
Auditor Name	KOST FORER GABBAY & KASIERER
Auditor Location	Tel-Aviv, Israel

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ (81,100)	$ 120,805	$ 71,396
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	(1,039)	414	995
Marketable Security, Gain (Loss) [Abstract]
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total	506	(502)	0
Reclassification of Cash Flow Hedge Gain (Loss) [Abstract]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	(48)	(3,488)	364
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	1,300	2,535	(1,308)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Total	1,252	(953)	(944)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total	719	(1,041)	51
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total	$ (80,381)	$ 119,764	$ 71,447

Transactions and Balances with Related Parties (Tables)

12 Months Ended

Dec. 31, 2023

Schedule of Related Party Transactions

Transactions with SUN Corporation


	Year Ended December 31,
	2023	2022	2021

Revenues	4,061	3,586	3,678

Balances with SUN Corporation


	December 31, 2023	December 31, 2022
Trade receivables	345	122

Fair value measurements - Schedule of Public and Private Warrants Measured at Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	$ 0	$ 116,863	$ 67,873
Warrant Liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	20,015	56,478
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	34,102	(36,463)
Ending balance, fair value measurement	54,117	20,015	56,478
Public Warrant Liability \| Level 1 \| Warrant Liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	12,960	35,200
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	18,439	(22,240)
Ending balance, fair value measurement	31,399	12,960	35,200
Private Placement Warrants \| Level 3 \| Warrant Liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	7,055	21,278
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	15,663	(14,223)
Ending balance, fair value measurement	$ 22,718	$ 7,055	$ 21,278

Other accounts payable and accrued expenses

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Other accounts payable and accrued expenses

Note 9. Other accounts payable and accrued expenses


	December 31, 2023		December 31, 2022

Governmental institution	$	2,646	$	1,227
Employees and related expenses	34,111		33,495
Income tax payable	833		2,853
Accrued expenses	6,161		6,244
Advances from customers	862		628
Other	232		1,006
	$	44,845	$	45,453

Lease - Schedule of Operating Lease (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Leases [Abstract]
Operating Lease, Cost	$ 4,934
Short-Term Lease, Cost	347
Variable Lease, Cost	269
Lease, Cost, Total	$ 5,550

Business combination - Schedule of Purchase Price Allocation Digital Clues LTD (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Nov. 11, 2021
Business Acquisition [Line Items]
Goodwill	$ 26,829	$ 26,829
Digital Clues LTD
Business Acquisition [Line Items]
Net assets			$ (890)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			3,524
Goodwill			17,366
Total			20,000
Digital Clues LTD \| Technology-Based Intangible Assets [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			3,347
Digital Clues LTD \| Customer Relationships [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			$ 177

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

Fair value measurements - Schedule of Level 3 Fair Value Measurement Inputs (Details) - Private Placement Warrants	Dec. 31, 2023 shares	Dec. 31, 2022 shares	Aug. 30, 2021 shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)			9,666,667
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)	9,666,667	9,666,667
Derivative liability, measurement input	0
Level 3 \| Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	11.5	11.5
Level 3 \| Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	8.66	4.36
Level 3 \| Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	2.66	3.66
Level 3 \| Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.519	0.529
Level 3 \| Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.0410	0.0413
Level 3 \| Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0

Summary of Significant Accounting Policies - Basic and Diluted Net Income (Loss) per Share (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based payment arrangement, option
Class of Warrant or Right [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	7,848,793	14,148,829	9,995,236
Restricted stock
Class of Warrant or Right [Line Items]
Number of shares (in shares)	7,500,000
Ordinary shares and vested restricted stock units
Class of Warrant or Right [Line Items]
Number of shares (in shares)	15,000,000
Public Warrant Liability
Class of Warrant or Right [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	19,999,449
Private Placement Warrants
Class of Warrant or Right [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	9,666,667

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Additional Cash Flow Elements, Operating Activities [Abstract]
Net Income (Loss)	$ (81,100)	$ 120,805	$ 71,396
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Share based compensation	18,998	13,708	6,480
Amortization of premium, discount and accrued interest on marketable securities	(1,106)	(372)	0
Depreciation and amortization	10,011	9,194	7,007
Deferred tax assets, net	5,125	(2,392)	(1,638)
Interest on deposits	(7,737)	(684)	0
Remeasurement of Warrant liability	34,102	(36,463)	(11,967)
Remeasurement of Restricted Sponsor Shares liability	29,715	(27,180)	(17,635)
Remeasurement of Price Adjustment Shares liabilities	55,531	(53,220)	(38,271)
Changes in Operating lease right-of-use assets	4,362	4,667	0
Changes in Operating lease liabilities	(4,196)	(5,955)	0
Decrease (increase) in trade receivables	2,271	(12,885)	(1,958)
Increase in deferred revenues	46,114	38,966	21,804
Increase in prepaid expenses and other current assets	(9,211)	(5,692)	(8,304)
(Increase) decrease in other non-current assets	(5,610)	227	(1,394)
Decrease (increase) in inventories	243	(3,680)	(1,798)
Increase (decrease) in trade payables	3,691	(5,471)	4,239
Increase (decrease) in other accounts payable and accrued expenses	734	(8,853)	5,107
Increase (decrease) in other long-term liabilities	121	(4,143)	2,984
Net Cash Provided by (Used in) Operating Activities, Total	102,058	20,577	36,052
Additional Cash Flow Elements, Investing Activities [Abstract]
Payments to Acquire Property, Plant, and Equipment	(5,231)	(6,897)	(5,111)
Payments to Acquire Businesses, Net of Cash Acquired	0	0	(20,000)
Payments to Acquire Intangible Assets	(2,687)	(2,188)	(3,000)
Payments to Acquire Marketable Securities	(55,317)	(89,364)	0
Proceeds from Sale and Maturity of Marketable Securities	56,336	22,277	0
Payments to Acquire Short-Term Investments	(89,000)	(76,000)	(21,000)
Proceeds from Sale of Short-Term Investments	73,359	60,941	94,337
Net Cash Provided by (Used in) Investing Activities, Total	(22,540)	(91,231)	45,226
Additional Cash Flow Elements, Financing Activities [Abstract]
Exercise of options	19,142	12,628	2,305
Proceeds from Employee Share Purchase Plan, net	2,623	1,337	0
Exercise of public warrants	0	5	0
Payment of dividend	0	0	(100,000)
Proceeds from Recapitalization transaction, net	0	0	29,298
Net cash provided by (used in) financing activities	21,765	13,970	(68,397)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect, Total	101,283	(56,684)	12,881
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	589	(1,644)	(754)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance	87,645	145,973	133,846
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance	189,517	87,645	145,973
Supplemental Cash Flow Information [Abstract]
Income Taxes Paid, Net	10,047	9,053	8,157
Noncash Investing and Financing Items [Abstract]
Fair Value of Assets Acquired	0	0	814
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	0	664	0
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 4,363	$ 0	$ 0

Summary of Significant Accounting Policies - Inventories (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Inventory write-offs	$ 608	$ 211	$ 230

Summary of Significant Accounting Policies - Costs to Obtain a Contract (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Sales commission expense	$ 9,596	$ 6,883	$ 5,405
Capitalized contract cost, gross	$ 6,245	$ 6,846

Prepaid expenses and other current assets (Tables)

12 Months Ended

Dec. 31, 2023

Prepaid Expense and Other Assets, Current [Abstract]

Schedule of Prepaid Expenses and Other Current Assets


	December 31, 2023		December 31, 2022

Advances to suppliers	$	598	$	790
Prepaid expenses	8,894		7,807
Government institutions	15,470		7,401
Other	1,438		1,087
	$	26,400	$	17,085

Taxes on income

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Taxes on income

Note 18. Taxes on income

A. Israeli taxation

1.Corporate tax rates in Israel:

The tax rates relevant to corporations in Israel in the years 2023, 2022 and 2021 is 23%. However, the effective tax rate reported by a company that derives income from a Preferred Enterprise or Preferred Technological Enterprise (as discussed below) is lower.

2.Tax benefits under the Law for Encouragement of Capital Investments, 1959 (“the Investment Law”) Approved/Beneficiary Enterprise

Pursuant to the Investment Law, the Company was awarded “Approved Enterprise” and “Beneficiary Enterprise” status under the government alternative benefits path beginning in 2003 until 2018 (included). During this period the Company was entitled to beneficial tax rates of 0% – 10%. The Company decided to terminate its “Approved” and ”Beneficiary Enterprise” status early and enjoy beneficial tax rates under the “preferred technological enterprise” status effective beginning 2019.

In the event of distribution of dividends from income taxable at 0% tax rate (the “Trapped Earnings”) as part of the Approved Enterprise or Beneficiary Enterprise statuses, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Approved or Beneficiary Enterprise’s.

During the year ended December 31, 2021, the Company distributed approximately $71,000 attributable to all of the Company’s Trapped Earnings and recorded a related income tax expense of approximately $7,000.

During October 2022, a final ruling was signed by the Company and the ITA, according to which, the Company paid approximately $4,900.

3.Tax benefits under the Law for Encouragement of Preferred Enterprise and Preferred Technology Enterprise

On May 16, 2017 the Knesset Finance Committee approved Encouragement of Capital Investment Regulations (Preferred Technological Income and Capital Gain of Technological Enterprise) — 2017 (hereinafter: “the Regulations”), which provides rules for applying the “Preferred Technological Enterprise” tax benefit track including the formula that provides the mechanism for allocating the technological income eligible for the benefits

Commencing in 2019 the Company elected the Preferred Technology Enterprise status to apply under the Law for the Encouragement of Capital Investments (the “Investment Law”). The approval is currently in affect for the tax years 2019 to 2023. The Company expects to continue to meet the conditions to be entitled to the “Preferred Technological Enterprise” status beyond 2023.

Income subject to the Preferred Technology Enterprise status is taxed at reduced tax rate of 12% and income from manufacturing activity in Area A is taxed at reduced tax rate of 7.5%.

4.Tax benefits under the Law for the Encouragement of Industry (Taxation), 1969:

Management believes that the Company currently qualifies as an "industrial company" under the above law and as such, is entitled to certain tax benefits including accelerated depreciation, deduction of public offering expenses in three equal annual installments and amortization of other intangible property rights for tax purposes.

5.Tax Benefits for Research and Development:

Israeli tax law (section 20A to the Israeli Tax Ordinance (New Version), 1961) allows a tax deduction for research and development expenses, including capital expenses, in the year in which they are paid. Such expenses must relate to scientific research in industry, agriculture, transportation or energy, and must be approved by the relevant Israeli government ministry, determined by the field of research. Expenses incurred in scientific research that are not approved by the relevant government ministry are amortized over a three-year period starting from the tax year in which they are paid.

6.Foreign Exchange Regulations:

Under the Foreign Exchange Regulations, the Company calculates its Israeli tax liability in U.S. dollars according to the Israeli Income Tax Regulations (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income), 1986. The tax liability, as calculated in U.S. dollars is translated into NIS according to the exchange rate as of December 31 of each year.

B.Income taxes on non-Israeli subsidiaries:

The Company’s subsidiaries incorporated in the US, Germany, Singapore, Australia, Brazil, UK, France, Canada, Japan and India are taxed according to tax laws in the countries of their residence. The Company’s effective tax rate depends on the geographical mix of where its profits are earned. In the year 2023, the Company’s U.S. subsidiary is subject to combined federal and state income taxes of 24% and the subsidiaries in Germany and Singapore are subject to corporation tax at a rate of approximately 33% and 17% respectively. As of December 31, 2023, the Company had approximately $45,431 undistributed earnings of its subsidiaries.

These undistributed earnings were designated as indefinitely reinvested.

In the event of a distribution of those earnings in the form of dividends, a sale of the subsidiaries, or certain other transactions, we may be liable for income taxes, subject to an adjustment, if any, for foreign tax credits and foreign withholding taxes payable to certain foreign tax authorities.

C.Deferred taxes

Deferred taxes recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and such amounts for income tax purposes. Significant components of the deferred tax liabilities and assets are as follows:


	December 31, 2023		December 31, 2022

Deferred tax assets:
Deferred research and development cost	$	2,661	$	4,410
Employee related liabilities	3,275		2,023
Intangible assets	857		991
Goodwill	1,647		2,851
Deferred revenues	2,563		2,167
Carryforward loss	—		1,826
Operating lease liability	2,732		2,094
Issuance costs	—		675
Marketable securities	13		189
Derivative instruments	—		52
Property and equipment	39		—
Other	749		765
Total deferred tax assets	14,536		18,043

Deferred tax liabilities:
Deferred costs	3,066		1,946
Intangible assets	337		497
Goodwill	445		237
Property and equipment	874		777
Operating lease right-of-use assets	2,652		2,022
Derivative instruments	119		—
Marketable securities	15		—
Other	4		53
Total deferred tax liabilities	7,512		5,532
Total deferred tax assets, net	$	7,024	$	12,511

A reconciliation of the amount that would result from applying the Company’s statutory tax rate in Israel to income before income tax expense to the reported amount of income tax expense allocated to continuing operations is as follows:


	Year Ended December 31,
	2023			2022			2021

Income before income taxes expense, as reported in the consolidated statements of operations	$	(75,563)		$	120,760		$	82,305
Statutory tax rate in Israel	23		%	23		%	23		%
Theoretical taxes on income	(17,379)			27,775			18,930
Foreign subsidiaries taxed at different tax rates	565			104			167
Preferred tax rates in Israel	9,713			(12,121)			(7,598)
Remeasurement of liability instruments	14,322			(14,024)			(8,145)
Non-deductible expense	823			400			1,363
Taxes in respect of prior years	(1,193)			103			(125)
Tax on dividend distributed from trapped earnings	—			(2,369)			7,068
Research and development tax credits	(2,087)			—			—
Other	773			87			(751)
Actual tax expense (income)	$	5,537		$	(45)		$	10,909

(Loss) income before income tax expense is comprised as follows:


	Year Ended December 31,
	2023		2022		2021

Domestic	$	(88,298)	$	110,187	$	71,434
Foreign	12,735		10,573		10,871
	$	(75,563)	$	120,760	$	82,305

Tax expense (income) allocated to continuing operations is comprised as follows:


	Year Ended December 31,
	2023		2022		2021

Current:
Domestic	$	3,010	$	(2,573)	$	9,665
Foreign	(2,876)		4,920		2,882
Total current tax expense:	134		2,347		12,547

Deferred:
Domestic	1,596		(85)		(10)
Foreign	3,807		(2,307)		(1,628)
Total deferred tax benefit	5,403		(2,392)		(1,638)
Total tax expense (income)	$	5,537	$	(45)	$	10,909

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:


	December 31, 2023		December 31, 2022

Unrecognized tax benefits, beginning of year	$	3,073	$	3,238
Decreases in tax positions for prior years	(436)		(452)
Increases in tax positions for current year	892		287
Unrecognized tax benefits, end of year	$	3,529	$	3,073

Interest expense recognized related to uncertain tax positions amounted to $173 , $129 and $92 in 2023 , 2022 and 2021, respectively. Total accrued interest as of December 31, 2023 and 2022 was $470 and $297, respectively, and were included in accrued expenses.

The Company currently does not expect unrecognized tax benefits to change significantly over the next 12 months, except in the case of settlements with tax authorities, the likelihood and timing of which is difficult to estimate.

The Company’s income tax assessments in Israel through the year 2017 are considered final.

The Company is subject to income tax in other jurisdictions outside of Israel, of which the major jurisdiction is the U.S. The Company’s operation in the US is subject to potential examination for tax years 2020 and afterwards.

Timing of the resolution of audits is highly uncertain and therefore, as of December 31, 2023, the Company cannot estimate the change in unrecognized tax benefits resulting from these audit within the next 12 months.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//740/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-21

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482526/740-270-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482603/740-30-50-2

+ Details

Fair value measurements - Schedule of Restricted Sponsor Shares and Price Adjustment Shares (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	$ 0	$ 116,863	$ 67,873
Restricted Sponsor Shares [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	17,532	44,712
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	29,715	(27,180)
Ending balance, fair value measurement	47,247	17,532	44,712
Price Adjustment Shares [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	26,184	79,404
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	55,531	(53,220)
Ending balance, fair value measurement	81,715	26,184	79,404
Restricted Sponsor And Price Adjustment Shares
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	43,716	124,116
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	85,246	(80,400)
Ending balance, fair value measurement	$ 128,962	$ 43,716	$ 124,116

Net income (loss) per share (Tables)

12 Months Ended

Dec. 31, 2023

Earnings Per Share [Abstract]

Summary of the Computation of Basic Losses Per Share

The following table sets forth the computation of basic losses and earnings per share:


	Year Ended December 31,
	2023		2022		2021
Numerator:
Net (loss) income	$	(81,100)	$	120,805	$	71,396
Basic net income attributable to Restricted sponsor shares	—		4,694		963
Basic net (loss) income attributable to Ordinary shareholders	(81,100)		116,111		70,433

Denominator:
Weighted average number of Ordinary shares used in computing basic net (loss) income per share	190,154,549		182,693,375		144,002,394
Basic net (loss) income per share of Ordinary shareholders	$	(0.43)	$	0.64	$	0.49
Weighted average number of Ordinary shares used in computing diluted net (loss) income per share	190,154,549		195,393,558		161,538,579
Diluted net (loss) income per share of Ordinary shareholders	$	(0.43)	$	0.59	$	0.44

Accumulated other comprehensive income (loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ 1,050	$ 331
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(581)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	1,300
Other comprehensive income (loss)	719	(1,041)	$ 51
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax	4	(502)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	506
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	0
Other comprehensive income (loss)	506
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax	875	(377)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(48)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	1,300
Other comprehensive income (loss)	1,252
Accumulated Foreign Currency Adjustment Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax	171	$ 1,210
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(1,039)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	0
Other comprehensive income (loss)	$ (1,039)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.

+ References + Details

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventory, Raw Materials and Supplies, Net of Reserves	$ 7,815	$ 7,451
Inventory, Finished Goods, Net of Reserves	2,125	2,725
Total inventory	$ 9,940	$ 10,176

Revenues - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
Revenues - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract with Customer, Liability	$ 242,823	$ 194,882	$ 159,409
Unbilled revenue	89,173	81,527
RevenueRemainingPerformanceObligation2023	331,996	276,409
ContractWithCustomerLiabilityRevenueRecognized2023	$ 141,307	$ 104,868

Shareholders’ equity (deficiency) - Schedule of Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, beginning balance (in shares)	20,457,660
Granted (in shares)	3,222,786
Exercised (in shares)	7,391,891
Forfeited (in shares)	560,379
Options outstanding, ending balance (in shares)	15,728,176	20,457,660
Exercisable (in shares)	11,441,966
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding, Weighted average exercise price per share, beginning balance (in USD per share)	$ 2,990
Granted, Weighted average exercise price per share (in USD per share)	6,440
Exercised, Weighted average exercise price per share (in USD per share)	2,580
Forfeited, Weighted average exercise price per share (in USD per share)	4,670
Options outstanding, Weighted average exercise price per share, ending balance (in USD per share)	3,830	$ 2,990
Exercisable, Weighted average exercise price per share (in USD per share)	$ 3,070.00
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, Weighted average remaining contractual term	6 years 2 months 23 days	6 years 4 months 20 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	5 years 3 months

Net income (loss) per share

12 Months Ended

Dec. 31, 2023

Earnings Per Share [Abstract]

Net income (loss) per share

Note 14. Net (loss) income per share

The following table sets forth the computation of basic losses and earnings per share:


	Year Ended December 31,
	2023		2022		2021
Numerator:
Net (loss) income	$	(81,100)	$	120,805	$	71,396
Basic net income attributable to Restricted sponsor shares	—		4,694		963
Basic net (loss) income attributable to Ordinary shareholders	(81,100)		116,111		70,433

Denominator:
Weighted average number of Ordinary shares used in computing basic net (loss) income per share	190,154,549		182,693,375		144,002,394
Basic net (loss) income per share of Ordinary shareholders	$	(0.43)	$	0.64	$	0.49
Weighted average number of Ordinary shares used in computing diluted net (loss) income per share	190,154,549		195,393,558		161,538,579
Diluted net (loss) income per share of Ordinary shareholders	$	(0.43)	$	0.59	$	0.44

Shareholders’ equity (deficiency)

Note 13. Shareholders’ equity (deficiency)

a.Stock Split

On August 30, 2021, the Company’s board of directors approved a 1:1.0422 reverse stock split. As a result, all ordinary shares, Preferred Shares, options for ordinary shares, restricted share units,exercise price and net income (loss) per share amounts were adjusted retroactively for all periods presented in these condensed consolidated financial statements as if the stock split and change in par value had been in effect as of the date of these condensed consolidated interim financial statements.

b.Ordinary Shares

As of December 31, 2023 and 2022, the Company was authorized to issue 3,454,112,863 shares of par value NIS 0.00001 per share ordinary share. The voting, dividend and liquidation rights of the holders of the Company’s common share is subject to and qualified by the rights, powers and preferences of the holders of the preferred shares as set forth below.

Common share confers upon its holders the following rights:

i.The right to participate and vote in the Company’s general meetings. Each share will entitle its holder, when attending and participating in the voting to one vote;

ii.Dividends or Distribution shall be paid or be made to the holders of Ordinary Shares, shall be in an amount equal the product of the dividend or distribution payable or made on each ordinary share determined as if all preferred shares had been converted into ordinary shares and the number of ordinary shares issuable upon conversion of such preferred share, in each case calculated on the record date for determination of holders entitled to receive such dividend or distribution; and

iii.The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the share held by them.

c.Redeemable Convertible Preferred shares rights

On June 17, 2019, the Company issued 39,779,261 Convertible Preferred shares for $2.765 per share (the “Original Issue Price”) for the total consideration of $101,205 (net of issuance costs).

On June 17, 2019, IGP Saferworld Limited Partnership (hereinafter: “IGP”), an investment vehicle of IGP Capital, a venture capital firm based in Israel, invested $110 million in the Company, in exchange for the Company’s redeemable convertible preferred shares, representing 24.4% of the Company’s outstanding ordinary and preferred shares (see also Note 1b and Note 13b). Following the IGP investment, the Company paid to its employees compensation in the amount of $4,034 includes in other expenses in the consolidated statements of operations and comprehensive income (loss).

On August 30, 2021, immediately before the consummation of the Merger with TWC, the Company’s Preferred Shares were converted into Ordinary Shares.

d.Option Plan, RSU’s and PSU’s:

On August 5, 2021, the Company adopted the 2021 Share Inventive Plan (the “2021 Share Incentive Plan). The 2021 Share Incentive Plan provides for the grant of share options (including incentive share options and non-qualified share options), ordinary shares, RSUs, PSUs, and other share-based awards.

The maximum aggregate number of shares that may be issued pursuant to awards under this 2021 Plan is 37,653,880. Out of which 12,435,797 were granted as of December 31, 2023.

As of December 31, 2023 the aggregate amount of options, RSUs and PSUs outstanding is 23,888,325.

A summary of the Company’s option activity and related information is as follows:


	Number of options	Weighted- average exercise price		Weighted- average remaining contractual term (in years)
Outstanding at December 31, 2022	20,457,660	$	2.99	6.39
Granted	3,222,786	6.44
Exercised	7,391,891	2.58
Forfeited	560,379	4.67
Outstanding at December 31, 2023	15,728,176	$	3.83	6.23
Exercisable at December 31, 2023	11,441,966	$	3.07	5.25

The weighted average fair values at grant date of options granted for the year ended December 31, 2023, 2022 and 2021were $3.59, $2.86 and $5.04 per share, respectively.

The total intrinsic value of options exercised during the years 2023, 2022 and 2021, was $33,237, $12,116, and $8,547, respectively.

The aggregate intrinsic value of the outstanding options at December 31, 2023, 2022 and 2021, represents the amount of 15,728,176, 18,121,448 and 25,440,041, respectively, outstanding options that are in-the-money as of such dates. The remaining 2,336,212 and 47,856 outstanding options are out-of-the-money as of December 31, 2022 and 2021, respectively, and their intrinsic value was considered as zero.

A summary of the Company’s RSUs and PSUs activity is as follows:


			December 31, 2023
			Number of RSUs
Unvested at beginning of year			6,391,352
Granted			5,850,513
Vested			2,216,312
Forfeited			1,865,404
Unvested, at end of year			8,160,149

The weighted average fair value at grant date of RSUs and PSUs granted for the year ended December 31, 2023, 2022 and 2021 was $5.75, $6.02 and $8.27 respectively.

The total aggregate fair value of shares vested during the years 2023, 2022 and 2021 was $13,805, $3,025 and $927 respectively.

As of December 31, 2023, the Company had approximately $52,917 of unrecognized compensation expense related to non-vested shares options, non-vested RSU’s and non-vested PSU’s expected to be recognized over a weighted average period of 2.95 years.

e.2021 Employee Share Purchase Plan:

On August 5, 2021, the Company adopted the 2021 Employee Share Purchase Plan (“ESPP”).

The aggregate number of Shares that may be issued pursuant to rights granted under the ESPP shall be 1,871,687 Shares. In addition, on the first day of each calendar year beginning on January 1, 2023 and ending on and including January 1, 2033, the number of Shares available for issuance under the Plan shall be increased by that number of Shares equal to the lesser of (a) 1.0% of the Shares outstanding on the last day of the immediately preceding calendar year, as determined on a fully diluted basis, and (b) such smaller number of Shares as may be determined by the Board. If any right granted under the ESPP shall for any reason terminate without having been exercised, the Shares not purchased under such right shall again become available for issuance under the ESPP.

As of December 31, 2023 and 2022, 587,579 and 290,053 ordinary shares had been issued under the ESPP. The ESPP is compensatory and, as such, results in recognition of compensation cost.

f.Share based compensation expenses related to the consolidated statements of operations recognized were comprised as follows:


	Year Ended December 31,
	2023		2022		2021

Cost of revenues	$	1,733	$	1,283	$	290
Research and development	4,673		2,974		1,076
Sales and marketing	6,478		5,041		2,332
General and administrative	6,114		4,410		2,782
	$	18,998	$	13,708	$	6,480

Other accounts payable and accrued expenses - Schedule of Accounts Payable and Accruals (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Taxes Payable, Current	$ 2,646	$ 1,227
Employee-related Liabilities, Current	34,111	33,495
Taxes Payable	833	2,853
Other Accrued Liabilities, Current	6,161	6,244
Contract With Customer, Customer Advances	862	628
Other Accounts Payable And Other Accrued Liabilities, Current	232	1,006
Other Accounts Payable and Accrued Liabilities	$ 44,845	$ 45,453

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on marketable securities, tax	$ 2	$ 189	$ 0
Unrealized gain (loss) on hedging transactions, tax	171	130	129
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	$ 1,252	$ (953)	$ (944)

Property and equipment, net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 49,149	$ 44,563
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(33,253)	(27,304)
Property, plant and equipment, net	15,896	17,259
Depreciation	6,664	6,368	$ 5,036
Other Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	582	546
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	10,461	10,203
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	7,465	6,674
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 30,641	$ 27,140

Derivative Instruments (Tables)

12 Months Ended

Dec. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Notional Amounts of Outstanding Derivative Positions


	Net Notional amount				Fair value (Level 2 within the fair value hierarchy)
	December 31				December 31,
	2023		2022		2023		2022
Option contracts to hedge payroll
expenses NIS	$	32,158	$	31,833	$	1,159	$	173
Forward contracts to hedge payroll
expenses (income) NIS	—		5,598		—		(229)
	$	32,158	$	37,431	$	1,159	$	(56)

Schedule of Derivative Liabilities at Fair Value

The fair value of the Company's outstanding derivative instruments at December 31, 2023 and 2022 is summarized below:


		Fair value of derivative instruments
		December 31,
	Balance Sheet line item	2023		2022
Derivative liabilities:
Foreign exchange option contracts	Prepaid expenses and other current assets	$	1,159	$	173
Foreign exchange forward contracts	Prepaid expenses and other current assets	—		—
Foreign exchange option contracts	Other account payable	(164)		(596)
Foreign exchange forward contracts	Other account payable	$	—	$	(229)

Derivative Instruments, Gain (Loss)

The effect of derivative instruments in cash flow hedging relationship on income and other comprehensive income for the year ended December 31, 2023, 2022 and 2021, is summarized below:


	Amount of (loss) gain recognized in other comprehensive income on derivative, net of tax (effective portion)
	Year ended December 31,
	2023		2022		2021
Derivatives in foreign exchange cash flow hedging relationships:
Forward contracts	$	(168)	$	(643)	$	110
Option contracts	120		(2,845)		254
	$	(48)	$	(3,488)	$	364

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

Derivatives in foreign exchange cash flow hedging relationships for the year ended December 31, 2023, 2022 and 2021 , is summarized below:


		Amount of gain (loss) reclassified from other comprehensive income into income (expenses), net of tax (effective portion)
		Year ended December 31,
	Statements of income line item	2023		2022		2021
Option contracts to hedge payroll	Cost of revenues and operating expenses	$	930	$	2,491	$	(657)
Forward contracts to hedge payroll	Cost of revenues and operating expenses	370		44		(651)
		$	1,300	$	2,535	$	(1,308)

Fair value measurements - Narrative (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Aug. 30, 2021 ₪ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of securities issued per warrant exercised (in shares)	1
Exercise price (USD per share) \| ₪ / shares	₪ 11.50
Days after completion of transaction in which award is exercisable	30 days
Expiration period	5 years
Price per share, company redemption option (USD per share) \| ₪ / shares	₪ 0.01
Minimum share price of company stock, in which company can redeem warrants (USD per share) \| ₪ / shares	₪ 18
Trading days within a 30-trading day period	20 days
Trading day period	30 days
Stock Issued During Period, Value, Warrants Exercised \| $			$ 5
Restricted stock
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		7,500,000
Ordinary shares and vested restricted stock units
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		15,000,000
The Sponsor \| TWC Tech Holdings II Corp. (“TWC")
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		13,500,000
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC")
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		7,500,000
Contingent consideration threshold trading days		20 days
Contingent consideration threshold consecutive trading days		30 days
Contingent consideration price adjustment expiration period		7 years
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche one
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		3,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 12.50
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche two
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		3,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 15.00
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche three
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		1,500,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 30.00
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC")
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		15,000,000
Contingent consideration threshold trading days		20 days
Contingent consideration threshold consecutive trading days		30 days
Contingent consideration terms, performance period		5 years
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche one
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 12.50
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche two
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 15.00
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche three
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 17.5
Public Warrant Liability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)	20,000,000
Exercise of public warrants (in shares)		500
Stock Issued During Period, Value, Warrants Exercised \| $		$ 5
Private Placement Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)	9,666,667
Private Placement Warrants \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)		9,666,667	9,666,667
Derivative liability, measurement input		0

Summary of Significant Accounting Policies - Revenue (Details)	12 Months Ended
	Dec. 31, 2023
Minimum
Disaggregation of Revenue [Line Items]
Term of software license agreement	1 year
Maximum
Disaggregation of Revenue [Line Items]
Term of software license agreement	3 years

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Taxes on income (Tables)

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Deferred Tax Assets and Liabilities

Significant components of the deferred tax liabilities and assets are as follows:


	December 31, 2023		December 31, 2022

Deferred tax assets:
Deferred research and development cost	$	2,661	$	4,410
Employee related liabilities	3,275		2,023
Intangible assets	857		991
Goodwill	1,647		2,851
Deferred revenues	2,563		2,167
Carryforward loss	—		1,826
Operating lease liability	2,732		2,094
Issuance costs	—		675
Marketable securities	13		189
Derivative instruments	—		52
Property and equipment	39		—
Other	749		765
Total deferred tax assets	14,536		18,043

Deferred tax liabilities:
Deferred costs	3,066		1,946
Intangible assets	337		497
Goodwill	445		237
Property and equipment	874		777
Operating lease right-of-use assets	2,652		2,022
Derivative instruments	119		—
Marketable securities	15		—
Other	4		53
Total deferred tax liabilities	7,512		5,532
Total deferred tax assets, net	$	7,024	$	12,511

Schedule of Effective Income Tax Rate Reconciliation


	Year Ended December 31,
	2023			2022			2021

Income before income taxes expense, as reported in the consolidated statements of operations	$	(75,563)		$	120,760		$	82,305
Statutory tax rate in Israel	23		%	23		%	23		%
Theoretical taxes on income	(17,379)			27,775			18,930
Foreign subsidiaries taxed at different tax rates	565			104			167
Preferred tax rates in Israel	9,713			(12,121)			(7,598)
Remeasurement of liability instruments	14,322			(14,024)			(8,145)
Non-deductible expense	823			400			1,363
Taxes in respect of prior years	(1,193)			103			(125)
Tax on dividend distributed from trapped earnings	—			(2,369)			7,068
Research and development tax credits	(2,087)			—			—
Other	773			87			(751)
Actual tax expense (income)	$	5,537		$	(45)		$	10,909

Schedule of Income before Income Tax, Domestic and Foreign

(Loss) income before income tax expense is comprised as follows:


	Year Ended December 31,
	2023		2022		2021

Domestic	$	(88,298)	$	110,187	$	71,434
Foreign	12,735		10,573		10,871
	$	(75,563)	$	120,760	$	82,305

Schedule of Components of Income Tax Expense (Benefit)

Tax expense (income) allocated to continuing operations is comprised as follows:


	Year Ended December 31,
	2023		2022		2021

Current:
Domestic	$	3,010	$	(2,573)	$	9,665
Foreign	(2,876)		4,920		2,882
Total current tax expense:	134		2,347		12,547

Deferred:
Domestic	1,596		(85)		(10)
Foreign	3,807		(2,307)		(1,628)
Total deferred tax benefit	5,403		(2,392)		(1,638)
Total tax expense (income)	$	5,537	$	(45)	$	10,909

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:


	December 31, 2023		December 31, 2022

Unrecognized tax benefits, beginning of year	$	3,073	$	3,238
Decreases in tax positions for prior years	(436)		(452)
Increases in tax positions for current year	892		287
Unrecognized tax benefits, end of year	$	3,529	$	3,073

Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Asset impairment charges	$ 0	$ 0	$ 0

Shareholders’ equity (deficiency)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

Shareholders’ equity (deficiency)

Note 13. Shareholders’ equity (deficiency)

a.Stock Split

b.Ordinary Shares

Common share confers upon its holders the following rights:

i.The right to participate and vote in the Company’s general meetings. Each share will entitle its holder, when attending and participating in the voting to one vote;

iii.The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the share held by them.

c.Redeemable Convertible Preferred shares rights

On June 17, 2019, the Company issued 39,779,261 Convertible Preferred shares for $2.765 per share (the “Original Issue Price”) for the total consideration of $101,205 (net of issuance costs).

On August 30, 2021, immediately before the consummation of the Merger with TWC, the Company’s Preferred Shares were converted into Ordinary Shares.

d.Option Plan, RSU’s and PSU’s:

The maximum aggregate number of shares that may be issued pursuant to awards under this 2021 Plan is 37,653,880. Out of which 12,435,797 were granted as of December 31, 2023.

As of December 31, 2023 the aggregate amount of options, RSUs and PSUs outstanding is 23,888,325.

A summary of the Company’s option activity and related information is as follows:


	Number of options	Weighted- average exercise price		Weighted- average remaining contractual term (in years)
Outstanding at December 31, 2022	20,457,660	$	2.99	6.39
Granted	3,222,786	6.44
Exercised	7,391,891	2.58
Forfeited	560,379	4.67
Outstanding at December 31, 2023	15,728,176	$	3.83	6.23
Exercisable at December 31, 2023	11,441,966	$	3.07	5.25

The weighted average fair values at grant date of options granted for the year ended December 31, 2023, 2022 and 2021were $3.59, $2.86 and $5.04 per share, respectively.

The total intrinsic value of options exercised during the years 2023, 2022 and 2021, was $33,237, $12,116, and $8,547, respectively.

A summary of the Company’s RSUs and PSUs activity is as follows:


			December 31, 2023
			Number of RSUs
Unvested at beginning of year			6,391,352
Granted			5,850,513
Vested			2,216,312
Forfeited			1,865,404
Unvested, at end of year			8,160,149

The weighted average fair value at grant date of RSUs and PSUs granted for the year ended December 31, 2023, 2022 and 2021 was $5.75, $6.02 and $8.27 respectively.

The total aggregate fair value of shares vested during the years 2023, 2022 and 2021 was $13,805, $3,025 and $927 respectively.

e.2021 Employee Share Purchase Plan:

On August 5, 2021, the Company adopted the 2021 Employee Share Purchase Plan (“ESPP”).

As of December 31, 2023 and 2022, 587,579 and 290,053 ordinary shares had been issued under the ESPP. The ESPP is compensatory and, as such, results in recognition of compensation cost.

f.Share based compensation expenses related to the consolidated statements of operations recognized were comprised as follows:


	Year Ended December 31,
	2023		2022		2021

Cost of revenues	$	1,733	$	1,283	$	290
Research and development	4,673		2,974		1,076
Sales and marketing	6,478		5,041		2,332
General and administrative	6,114		4,410		2,782
	$	18,998	$	13,708	$	6,480

Lease - Narrative (Details)	Dec. 31, 2023
Leases [Abstract]
Operating lease, remaining lease term	10 years 6 months

Summary of Significant Accounting Policies - Segment Reporting (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) segment	Dec. 31, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments \| segment	1
Long-Lived Assets	$ 30,156	$ 32,912
EMEA [Member]
Segment Reporting Information [Line Items]
Long-Lived Assets	20,691	26,595
Americas [Member]
Segment Reporting Information [Line Items]
Long-Lived Assets	8,024	5,712
Asia Pacific [Member]
Segment Reporting Information [Line Items]
Long-Lived Assets	$ 1,441	$ 605

Consolidated Statements of Stockholders' Equity (Deficiency) - USD ($)
$ in Thousands

Total

Preferred Stock [Member]

Ordinary shares

Additional Paid-in Capital [Member]

Treasury Stock, Common [Member]

AOCI Attributable to Parent [Member]

Retained Earnings [Member]

Temporary equity, beginning balance (in shares) at Dec. 31, 2020

39,779,261

Temporary equity, beginning balance at Dec. 31, 2020

$ 101,205

Beginning balance (in shares) at Dec. 31, 2020

^[1]

124,671,507

Beginning balance at Dec. 31, 2020

$ 63,804

$ 0

^[2]

$ 34,226

$ (85)

$ 1,321

$ 28,342

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net Income (Loss)

71,396

Other comprehensive income (loss)

APIC, Share-Based Payment Arrangement, Increase for Cost Recognition

6,480

Exercise of share option, vested RSUs and ESPP (in shares)

^[1]

2,804,827

Stock Issued During Period, Value, Stock Options Exercised

2,305

Dividends

(100,000)

(78,700)

(21,300)

Conversion of preferred shares (in shares)

(39,779,261)

39,779,261

Exercise of share options, vested RSUs and ESPP

101,205

$ (101,205)

101,205

Temporary equity, ending balance (in shares) at Dec. 31, 2021

Temporary equity, ending balance at Dec. 31, 2021

$ 0

Ending balance (in shares) at Dec. 31, 2021

^[1]

187,680,294

Ending balance at Dec. 31, 2021

(73,347)

$ 0

(153,072)

(85)

1,372

78,438

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net Income (Loss)

120,805

Other comprehensive income (loss)

(1,041)

APIC, Share-Based Payment Arrangement, Increase for Cost Recognition

13,708

Stock Issued During Period, Value, Stock Options Exercised

13,735

Conversion of preferred shares (in shares)

5,333,361

^[1]

Exercise of share options, vested RSUs and ESPP

$ 0

13,735

Exercise of public warrants (in shares)

500

Stock Issued During Period, Value, Warrants Exercised

$ 5

Temporary equity, ending balance (in shares) at Dec. 31, 2022

Temporary equity, ending balance at Dec. 31, 2022

$ 0

Ending balance (in shares) at Dec. 31, 2022

193,014,155

^[1]

Ending balance at Dec. 31, 2022

$ 73,865

$ 0

(125,624)

(85)

331

199,243

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net Income (Loss)

(81,100)

Other comprehensive income (loss)

719

APIC, Share-Based Payment Arrangement, Increase for Cost Recognition

$ 18,998

18,998

Exercise of share option, vested RSUs and ESPP (in shares)

7,391,891

10,216,773

^[1]

Stock Issued During Period, Value, Stock Options Exercised

$ 21,730

21,730

Temporary equity, ending balance (in shares) at Dec. 31, 2023

Temporary equity, ending balance at Dec. 31, 2023

$ 0

Ending balance at Dec. 31, 2023

$ 34,212

$ 0

$ (84,896)

$ (85)

$ 1,050

$ 118,143

[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 13, Shareholders’ equity (deficiency), for details.
[2]	Less than US$ 1.

Taxes on income - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized Tax Benefits, Beginning Balance	$ 3,073	$ 3,238
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	(436)	(452)
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions	892	287
Unrecognized Tax Benefits, Ending Balance	3,529	3,073	$ 3,238
Uncertain Tax Positions
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Interest Expense	173	129	92
Investments, Owned, Federal Income Tax Note [Line Items]
Interest Expense	$ 173	$ 129	$ 92

- Definition

Amount of the cost of borrowed funds accounted for as interest expense.

+ References + Details

Revenues (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table provides information about disaggregated revenue by geographical areas


	Year Ended December 31,
	2023		2022		2021

EMEA	$	112,247	$	92,749	$	88,441
America	172,154		141,920		126,929
APAC	40,709		35,982		30,876
Total	$	325,110	$	270,651	$	246,246

Summary of Contract Balances

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:


	December 31, 2023		December 31, 2022
Contract liabilities, current	$	195,725	$	152,709
Contract liabilities, non-current	47,098		42,173

Derivative Instruments - Schedule of Cash Flow Hedging Relationship on Income and Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	$ (48)	$ (3,488)	$ 364
Foreign Exchange Forward [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	(168)	(643)	110
Foreign Exchange Option [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	$ 120	$ (2,845)	$ 254

Summary of Significant Accounting Policies - Stock-Based Compensation (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	5 years 3 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Exercise price (in USD per share)	$ 2,580
Share-based payment arrangement, option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	10 years	10 years	10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	6 years 1 month 9 days	6 years 1 month 9 days	6 years 1 month 9 days
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in USD per share)	$ 4.95	$ 4.79	$ 5.41
Minimum \| Share-based payment arrangement, option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate	50.30%	43.20%	35.90%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	3.70%	2.00%	1.30%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%	0.00%
Fair value of Ordinary Share (in USD per share)	$ 4.95	$ 4.79	$ 5.41
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in USD per share)	$ 7.99	$ 6.60	$ 8.27
Maximum \| Share-based payment arrangement, option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate	51.80%	51.90%	52.70%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.50%	4.20%	1.40%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate			5.00%
Fair value of Ordinary Share (in USD per share)	$ 7.99	$ 6.60	$ 8.27

Derivative Instruments - Narrative (Details)	12 Months Ended
Derivative Instruments - Narrative (Details)	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Maximum length of time hedged in cash flow hedge	1 year

Summary of Significant Accounting Policies - Liability in Respect of Employees Severance Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Severance pay expense	$ 4,305	$ 4,392	$ 4,067
Employer matching contribution, percent of employees' gross pay	6.00%
Defined contribution plan, employer contributions	$ 2,043	$ 1,711	$ 1,455

General	12 Months Ended
General	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General	Note 1. General a.Cellebrite DI Ltd. (the “Company”), an Israeli company, was incorporated on April 13, 1999 as a private company, and began its operations in July 1999. The Company and its wholly owned subsidiaries deliver a Case to Closure platform, comprising software and services for legally sanctioned investigations. The Company’s Case to Closure platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations The Company’s primary shareholder is SUNCORPORATION, a public Company traded in the Japanese market (See also Note 20). b.On April 8, 2021, the Company entered into a Business Combination Agreement and Plan of Merger (the “Merger Agreement”) with TWC Tech Holdings II Corp. (“TWC”), a public listed company in Nasdaq and Cupcake Merger Sub, Inc., a new wholly-owned subsidiary of Cellebrite (the “Merger Sub”) in the USA. TWC is a Special Purpose Acquisition Company (“SPAC”). On August 30, 2021, the Merger was consummated. Upon the terms and subject to the conditions of the Merger Agreement, at the Effective Time, Merger Sub merged with and into TWC, the separate corporate existence of Merger Sub ceased and TWC became the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). TWC became a wholly-owned subsidiary of the Company and the security holders of TWC became security holders of the Company. In December 2023, TWC was dissolved. The merger was accounted as a recapitalization, with no goodwill or other intangible assets recorded, in accordance with U.S. GAAP. Under this method of accounting, the Company has been determined to be the accounting acquirer. On the date of Closing of the Merger (the “Closing”) and prior to the Merger becoming effective by acceptance of the Merger Certificate for filing by the Secretary of State of the State of Delaware, and prior to the Company’s Preferred Share conversion into Ordinary Shares as described below, an initial dividend of $21,300 (“Initial Dividend”) and an additional dividend of $78,700 (“Additional Dividend”) were paid to the holders of Company’s Ordinary Shares, Preferred Shares and vested restricted share units (“RSU”) (all the “Company Shareholders”). Immediately after the payment of the Initial Dividend and the Additional Dividend and prior to the Effective Time each Company Preferred Share was automatically converted into Ordinary Share in accordance with the terms in Cellebrite’s Article of Association. Immediately following such conversion but prior to the Effective Time, the Company effected a reverse stock split of each Company Ordinary Share into such number of Company Ordinary Shares, which set the Ordinary Share value at $10 (See also Note 13 .a). Furthermore, Cellebrite issued TWC security holders the following securities at the Effective Time: each Public Share was converted into the right to receive one (1) Ordinary Share (the “Per Share Merger Consideration”). At the Effective Time each private warrant of TWC and each Public Warrant was converted into a warrant of Cellebrite, exercisable for the amount of Per Share Merger Consideration that the holder thereof would have received if such warrant had been exercisable and exercised immediately prior to the Merger. Additionally, each option and restricted share unit of Cellebrite remain outstanding, subject to adjusted terms to reflect the effect of the Stock Split on Ordinary Shares. Concurrently with the execution of the Merger Agreement, certain accredited investors (the “PIPE Investors” and each, a “PIPE Investor”) entered into share purchase agreements (the “Share Purchase Agreements” and each, a “Share Purchase Agreement”) pursuant to which the PIPE Investors committed to purchase Ordinary Shares from certain Cellebrite shareholders at a purchase price of $10.00 per share in an aggregate number equal to 30,000,000 and an aggregate purchase price of $300,000 (the “PIPE Investments” and each, a “PIPE Investment”) on the closing date of August 30, 2021 (the “Closing Date”), which were converted into 30,000,000 Ordinary Shares upon the consummation of the Merger (the “PIPE Shares”). The PIPE Investment closed immediately prior to the Merger. c.On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets (the “DC Assets”), for a total consideration of $20,000. The DC Assets provide the ability to view, collect, and analyze information from on-line open sources, and produce actionable intelligence. See also Note 3.

Intangible assets, net (Tables)

12 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Definite-Lived Intangible Assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Finite-lived intangible assets:


	December 31, 2023		December 31, 2022


Original amounts:
Core technology	$	15,950	$	13,263
Trade name	3,900		3,900
Customer relationship	177		177
	20,027		17,340
Accumulated amortization:
Core technology	5,657		3,303
Trade name	3,738		2,763
Customer relationship	38		20
	9,433		6,086
Intangible assets, net
	$	10,594	$	11,254

a. Amortization expense amounted to $3,347, $2,826 and $1,971 for the years ended December 31, 2023, 2022 and 2021, respectively.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

The expected future amortization expenses by year related to the intangible assets as of December 31, 2023 are as follows:




2024	$	3,227
2025	3,060
2026	2,543
2027	1,281
2028 and thereafter	483
	$	10,594

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Basis of presentation

Basis of presentationThe consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP).

Financial statements in United States dollars

The currency of the primary economic environment in which the operations of Cellebrite DI Ltd. and certain subsidiaries are conducted is the U.S. dollar ("dollar"); thus, the dollar is the functional currency of Cellebrite DI Ltd. and certain subsidiaries.

Cellebrite DI Ltd. and certain subsidiaries' transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been remeasured to dollars in accordance with ASC 830, “Foreign Currency Matters”. All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of income as financial income or expenses, as appropriate.

For those subsidiaries whose functional currency has been determined to be a non-dollar currency, assets and liabilities are translated at year-end exchange rates and statement of income items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity (deficiency).

Use of estimates

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods and accompanying notes. Actual results could differ from those estimates.

Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligation, the fair value of acquired intangible assets and goodwill in a business combination, share-based compensation, unrecognized tax benefits, marketable securities, fair value measurement of restricted sponsor shares liability, price adjustment shares liability and warrant liabilities.

Principles of consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation.

Cash and cash equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents.

Short Term Bank Deposit

Short-term bank deposits consist of bank deposits with original maturities of more than three months and up to twelve months.

Marketable securities

The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments—Debt Securities”. Management determines the appropriate classification of its investments in the debt securities at the time of purchase and re-evaluates such determination at each balance sheet date.

As of December 31, 2023 and 2022, all of the Company's marketable securities investments were classified as "available-for-sale" ("AFS") and are carried at fair value. Unrealized gains and losses are reported in a separate component of shareholders' equity (deficiency) in accumulated other comprehensive income, net of taxes. Gains and losses are recognized when realized, on a specific identification basis, in the Company’s consolidated statements of income.

For each reporting period, the Company evaluates whether declines in fair value below the amortized cost are due to expected credit losses, as well as the Company's ability and intention to hold the investment until a forecasted recovery occurs, in accordance with ASC 326. Allowance for credit losses on AFS debt securities are recognized as a charge in financial expenses (income) and other, net, on the consolidated statements of income, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive (loss) income. As of December 31, 2023 and 2022 credit losses were immaterial.

Trade Receivable

Trade receivables are recorded net of credit losses allowance for any potential uncollectible amounts.

The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical collectability experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.

As of December 31, 2023 and 2022, the allowances for credit losses of trade receivable were $1,583 and $1,904 respectively.

The Company writes off receivables when they are deemed uncollectible, having exhausted all collection efforts. Actual collection experience may not meet expectations and may result in increased bad debt expense.

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the “moving average cost” method. Inventory write-downs are provided to cover technological obsolescence, excess inventories and discontinued products.

Inventory write-down is measured as the difference between the cost of the inventory and market based upon assumptions about future demand, and is charged to cost of revenues. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

During the years ended December 31, 2023, 2022 and 2021, the Company recorded inventory write-offs in the amounts of $608, $211 and $230, respectively. Such write-offs were included in cost of revenues.

Property and equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.

Impairment of long-lived assets

Long-lived assets, including property and equipment, Right-of-use assets and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.

During the year ended December 31, 2023, 2022 and 2021, no impairment losses have been identified.

Leases

The Company determines if an arrangement meets the definition of a lease at the inception of the lease.

Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease agreement. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of the lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses the Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments.

Lease term may include options to extend or terminate the lease when it is reasonably certain that the Company would exercise and extend option and not exercise a termination option. The Company elected to not recognize a lease liability and a ROU asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate lease and non-lease components for its leases..

Payments under the Company’s lease agreements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and liabilities.

Revenue recognition and Costs to obtain a contract

Revenue recognition

The Company’s revenues are comprised of four main categories: (a) Subscription Services, including support services (updates, upgrades and technical support) on term-based licenses; (b) Term Licenses; (c) other non-recurring; and (d) professional services.

The Company recognizes revenue pursuant to the five-step framework contained in ASC 606, Revenue from Contracts with Customers: (i) identify the contract with a customer; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations

The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users.

In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to receive in exchange for these goods or services.

The Company determines that it has a contract with a customer when each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation.

Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract.

The Company’s software licenses either provide its customers the right to use its software for a fixed term, or a perpetual right to use its software, in most cases between a one-year and three-year time frame. The Company concluded that the software license is distinct as the customer can benefit from the software on its own.

Subscription revenue is derived from maintenance and support under renewable subscription, fee-based contracts that include unspecified software updates and upgrades released when and if available as well as software support. Customers with active subscriptions are also entitled to our technical customers’ support. Performance obligations related to software maintenance services generally have a consistent continuous pattern of transfer to a customer during the contract period.

Other non-recurring revenue derived mostly from hardware sold mainly in conjunction with new software license, perpetual license and usage-based fees.

Professional services revenues primarily consist of: (i) certified training classes by Cellebrite Academy; (ii) our advanced services; (iii) implementation of our products in connection with our software licenses and (iv) on premise contracted customer success and technical support.Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract.

The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring products or delivery of services to the customer. Payment terms generally are 30 days. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). The Company does not offer right of return to its contracts.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation. The Company uses judgment in determining the SSP for its products and services. The Company typically assesses the SSP for its products and services on a periodic basis or when facts and circumstances change. To determine SSP, the Company maximizes the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include the entity specific factors such as assessment of historical data of bundled sales of software licenses with other promised goods and services, and pricing strategies to estimate the price the Company would charge if the products and services were sold separately.

The Company satisfies performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. Revenues related to the license for proprietary software are recognized when the control over the license is provided to the customer and the license term begins. Revenue related to software update and upgrades are recognized ratably over the service period. Revenues related to other professional services are recognized as services are performed.

N. Contract acquisition cost

The Company capitalizes sales commission as costs of obtaining a contract when they are incremental and if they are expected to be recovered. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. The Company determines whether costs should be deferred based on its sales compensation plans and if the commissions are incremental and would not have occurred absent the customer contract.

Sales commissions for the renewal of a contract are considered commensurate with the sales commissions paid for the acquisition of the initial contract given no substantive difference in commission rates in proportion to their respective contract values.

Amortization of sales commissions are consistent with the pattern of revenue recognition of each performance obligation and are included in sales and marketing expense in the consolidated statements of operations.

The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No impairment losses of capitalizes sales commissions were recorded during the periods presented.

Amortization of deferred contract acquisition cost for the year ended December 31, 2023, 2022 and 2021 were $9,596, $6,883 and $5,405 respectively.

Assets recognized from the costs incurred to obtain a contract were $6,245 and $6,846 as of December 31, 2023 and 2022, respectively.

Research and development costs

Research and development

Research and development expenses are primarily comprised of costs of the Company’s research and development personnel and other development related expenses. Research and development costs are expensed as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization

Internal use software

Costs incurred to develop internal-use software are capitalized and amortized over the estimated useful life of the software. In accordance with ASC Topic, 350-40, “Internal-Use Software,” capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed, the Company has committed project funding and it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred.

Severance pay

Employee benefit plans

a.Israeli Severance Pay - The Israeli Severance Pay Law, 1963 ("Severance Pay Law"), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one month salary for each year of employment, or a portion thereof.

The majority of the Company's liability for severance pay is covered by the provisions of Section 14 of the Severance Pay Law ("Section 14"). Under Section 14, employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, made on behalf of the employee with insurance companies. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees.

As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company's balance sheet.

For the year ended December 31, 2023, 2022 and 2021 severance pay expenses amounted to $4,305, $4,392 and $4,067 respectively.

b.The US Subsidiary has a defined contribution plan (the “Contribution Plan”) under the provisions of Section 401(k) of the Internal Revenue Code (the “Code”) which covers eligible U.S. employees as they are defined in the Contribution Plan. Participants may elect to contribute up to a maximum amount prescribed by the Code. The Company, at its discretion, makes matching contributions to the greater of 6% of the participant’s compensation. For the year ended December 31, 2023, 2022 and 2021, the Company made 401(k) plan contributions of approximately $2,043, $1,711 and $1,455, respectively.

Advertising Expenses

Advertising Expenses Marketing events expenses and other related marketing expenses are charged to expense as incurred.

Income taxes

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period of enactment. A valuation allowance is provided, if necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. Deferred tax assets and deferred tax liabilities are presented under long-term assets.

The Company implements a two-step approach to recognize and measure uncertainty in income taxes. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is greater than 50 percent (cumulative basis) likely to be realized upon settlement. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company classifies interest and penalties related to unrecognized tax benefits as part of income taxes.

Stock-Based Compensation

The Company accounts for share-based compensation to employees and non-employees in accordance with ASC 718, “Compensation — Stock Compensation”, (“ASC 718”), which requires companies to estimate the fair value of equity-based payment awards on the date of grants based on the fair value of the awards granted.

The Company grants awards that vest upon the satisfaction of service condition and in certain grant market conditions.

For awards with graded vesting schedule subject to service condition, the Company recognize compensation costs based on the straight line attribution method over the requisite service period of the awards.

The Company estimate the fair value of share options granted using the Black-Scholes-Merton option-pricing model and for ESPP awards Monte Carlo pricing model and acceleration method.

The Company measures the grant date fair value of its RSUs based on the closing market price of the ordinary share on the date of grant. For PSUs subject to market conditions, the Company uses a Monte Carlo simulation model, which utilizes multiple inputs to estimate payout level and the probability that market conditions will be achieved.

The Company used the following weighted-average assumptions for options granted to employees and non-employees:


	Year ended December 31,
	2023	2022	2021
Contractual period in years	10	10	10
Volatility	50.3% - 51.8%	43.2% - 51.9%	35.9% - 52.7%
Risk free interest rate	3.7% - 4.5%	2.0% - 4.2%	1.3% - 1.4%
Dividend yield	0%	0%	0% - 5%
Exercise price	$4.95 - $7.99	$4.79 - $6.60	$5.41 - $8.27
Fair value of Ordinary Share	$4.95 - $7.99	$4.79 - $6.60	$5.41 - $8.27
Expected term	6.11	6.11	6.11

The fair value of ESPP was estimated on the grant date using Monte Carlo valuation methodology with the following weighted average assumptions:


						Year Ended December 31,
						2023

Volatility						39.7%-50.5%
Expected term						6 months
Risk-free interest rate						4.2%-5.1%
Share price						$4.69-$8.42
Dividend yield						0%

These assumptions and estimates were determined as follows:

Fair value of Ordinary shares — The Company’s Ordinary shares have a limited history of being publicly traded. Prior to the consummation of the merger, the fair value was determined by management, with input from valuation reports prepared by third-party valuation specialists. In determining the fair value of ordinary shares subsequent to the consummation of the Merger agreement, the board of directors considered the grant date fair value for share-based awards as of the closing price of the Company’s ordinary shares on NASDAQ on the business day prior to grant date.

Risk-free interest rate — The Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect as of the date of grant.

Expected term — The expected term of options granted is based on historical experience and represents the period of time that options granted are expected to be outstanding. Since the Company doesn’t have sufficient historical share exercise data to calculate the expected term of the share options. The Company determines the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the options.

Expected volatility Options — Since the Company has a limited trading history of its Ordinary shares, there is not sufficient historical volatility for the expected term of the share options. The expected volatility is derived: (i) historical volatility of comparable companies, in accordance with the expected remaining lives of the option (ii) historical volatility of the Company’s publicly traded shares, commencing August 30, 2021 and (iii) implied volatility of the Company’s publicly traded warrants.

Expected Volatility ESPP — was based on Cellebrite’s historical share price volatility, on a daily basis, for 6 months.

Expected dividend yield— The Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield.

Fair value measurements

The Company accounts for fair value in accordance with ASC 820, “Fair Value Measurements and Disclosures”. Fair value is defined under ASC 820 as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:

• Level 1: Quoted prices in active markets for identical assets or liabilities.

• Level 2: Inputs other than Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

• Level 3: Unobservable inputs for the asset or liability used to measure fair value that are supported by little or no market activity and that re significant to the fair value of the asset or liability at measurement date.

The carrying value of trade receivable and payables and the Company’s cash and cash equivalents and short-term deposits, approximates fair value due to the short time to expected payment or receipt of cash.

Derivative instruments

The Company accounts for derivatives and hedging based on ASC No. 815, “Derivatives and Hedging” (“ASC No. 815”). ASC No. 815 requires the Company to recognize all derivatives on the balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, as well as the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. If the derivatives meet the definition of a hedge and are designated as such, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in accumulated other comprehensive income until the hedged item is recognized in earnings.

The Company has instituted a foreign currency cash flow hedging program using foreign currency forward contracts (“derivative instruments”) in order to hedge the exposure to variability in expected future cash flows resulting from changes in related foreign currency exchange rates. The Company hedges portions of its forecasted expenses denominated in NIS. These transactions are designated as cash flow hedges, as defined under ASC 815, “Derivatives and Hedging”.

The Company measured the fair value of the contracts in accordance with ASC No. 820 (classified as level 2 of the fair value hierarchy). These contracts met the requirement for cash flow hedge accounting and, as such, gains (losses) on the contracts are recognized initially as component of Accumulated Other Comprehensive (loss) income in the balance sheets and reclassified to the statements of (loss) income in the period the related hedged items affect earnings.

Goodwill

Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350, “Intangible — Goodwill and Other”, goodwill is not amortized, but rather is subject to an annual impairment test.

ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, the fourth quarter, or between annual tests in certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value. The Company operates in one operating segment, and this segment is the only reporting unit.

ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update (“ASU”) No. 2017-04, Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.

The Company performs the goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present and compares the fair value of the reporting unit with its carrying value. There were no impairment charges to goodwill during the period presented.

Intangible assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.

Business combination

The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company estimated the future expected cash flows from acquired core technology and acquired trade name from a market participant perspective, useful lives and discount rates. In addition, management makes significant estimates and assumptions, which are uncertain, but believed to be reasonable.

Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates.

Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred.\

Concentrations of credit risk

Financial instruments that potentially expose the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments, restricted cash, trade receivables and other receivables.

The majority of the Company’s cash and cash equivalents are invested in deposits mainly in dollars with major international banks. Generally, these cash and cash equivalents and short term investment may be redeemed upon demand. Management believes that the financial institutions that hold the Company’s and its subsidiaries’ cash and cash equivalents are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these assets.

The Company’s trade receivables are geographically diversified and derived from sales to customers all over the world. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions. The Company and its subsidiaries generally do not require collateral; however, in certain circumstances, the Company and its subsidiaries may require letters of credit, additional guarantees or advance payments.

The Company’s marketable securities consist of investments in government, corporate and government sponsored enterprises debentures. The Company’s investment policy, approved by the Board of Directors, limits the amount that the Company may invest in any one type of investment, or issuer, thereby reducing credit risk concentrations.

The Company enter into foreign currency forward and option contracts intended to protect cash flows resulting from scheduled payments such as payroll and rent related expenses against the volatility in value of forecasted non-dollar currency. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. See Note 2 V and N ote 10 for additional information.

Segment reporting and information

AA. Segment information

The Company identifies operating segments in accordance with ASC Topic 280, “Segment Reporting” as components of an entity for which discrete financial information is available and is regularly reviewed by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and evaluating financial performance. The Company operates in one operating and reportable segment. Financial information is evaluated regularly by the chief operating decision maker, who is the Company’s CEO, in deciding how to allocate resources and assessing performance. The Company’s chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level.

Basic and diluted net income (loss) per share

Basic and diluted net (loss) income per share

The Company computes net income per share using the two-class method required for participating securities. The two-class method requires income available to Common shareholders for the period to be allocated between Common shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The holders of the Company's participating securities are entitled to dividends that would be distributed to the holders of Common shares, on a pro-rata basis. Diluted earnings per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period.

The Company's participating securities consists of the Restricted sponsor share ,which, in the event of a dividend distribution, will be entitled to non-forfeitable dividends on a proportional basis with the common shares. The Company does not allocate losses to these participating securities as they do not share in the Company's losses.

The potentially dilutive share options to purchase ordinary shares that were excluded from the computation amounted to 7,848,793 14,148,829 and 9,995,236 for the years ended December 31, 2023, 2022 and 2021, respectively, because including them would have been anti-dilutive.

The Restricted sponsor shares and Price adjustments shares, in the amount of 7,500,000 and 15,000,000, respectively, that are subject to the occurrence of certain conditions, were excluded from the diluted net income per share calculation for the years ended December 31, 2023, 2022 and 2021

Public warrants and Private warrants in the amount of 19,999,449 and 9,666,667, were excluded from the diluted income per share for the years ended December 31, 2023, 2022 and 2021, as the inclusion would have been anti-dilutive.

Recently issued accounting pronouncements

As an “Emerging growth company,” the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.

Recently adopted accounting pronouncements:

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which resulted more timely recognition of losses. The accounting standard is effective for the fiscal year beginning on January 1, 2023, including interim periods within that year.

The adoption did not have a material impact on the Company’s consolidated financial statements.

Recently issued accounting pronouncements not yet adopted:

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures to improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses on an interim and annual basis. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods for the fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. Early adoption is permitted. The Company is currently evaluating the effect of adopting the ASU on its disclosures.

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as provide additional information for reconciling items that meet a quantitative threshold. Further, the ASU requires certain disclosures of state versus federal income tax expense and taxes paid. The amendments in this ASU are required to be adopted for fiscal years beginning after December 15, 2024. Early adoption is permitted and the amendments should be applied on a prospective basis. The Company is currently evaluating the effect of adopting the ASU on its disclosures

Financial income, net (Details) - USD ($) $ in Thousands	12 Months Ended
Financial income, net (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Income, Nonoperating [Abstract]
Investment Income, Interest	$ 8,888	$ 1,603	$ 847
Foreign Currency Transaction Gain, before Tax	585	1,736	51
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	0	116,863	67,873
Other Nonoperating Income	1,828	741	276
Liability for Future Policy Benefit, Remeasurement Gain (Loss)	(119,348)	0
Other Expense, Nonoperating [Abstract]
Bank Costs	(233)	(187)	(166)
Foreign Currency Transaction Loss, before Tax	(379)	(891)	(245)
Other Nonoperating Expense	(141)	(149)	(153)
Nonoperating Income (Expense), Total	$ (108,800)	$ 119,716	$ 68,483

Financial income, net (Tables)

12 Months Ended

Dec. 31, 2023

Nonoperating Income (Expense) [Abstract]

Schedule of Net Financial Income


	Year Ended December 31,
	2023		2022		2021
Financial income:
Interest on deposits	$	8,888	$	1,603	$	847
Foreign currency translation differences	585		1,736		51
Remeasurement of liability instruments	—		116,863		67,873
Other	1,828		741		276

Financial expenses:
Remeasurement of liability instruments	(119,348)		—		—
Bank charges	(233)		(187)		(166)
Changes in exchange rates	(379)		(891)		(245)
Other	(141)		(149)		(153)
	$	(108,800)	$	119,716	$	68,483

Business combination (Tables)

12 Months Ended

Dec. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The purchase price allocation for the acquisition has been determined as follows:


	Amount
Net assets	$	(890)
Technology	3,347
Customer relationship	177
Goodwill	17,366
Total	$	20,000

Summary of Identifiable Intangible Assets Acquired

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition:


	Fair Value		Useful Life
	US$ thousands		In years
Core technology	3,347		7
Customer relationship	177		10
Total identifiable intangible assets	$	3,524

Inventories

12 Months Ended

Dec. 31, 2023

Inventory Disclosure [Abstract]

Inventories

Note 7. Inventories


	December 31, 2023		December 31, 2022

Raw materials	$	7,815	$	7,451
Finished goods	2,125		2,725
	$	9,940	$	10,176

Summary of Significant Accounting Policies - Derivative Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag	derivative instruments liabilities and assets
Derivative asset	$ 995	$ 652

- Definition

Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-12

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(3)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5C
-Subparagraph (SX 210.12-13C(Column H)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(3)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SX 210.12-13(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5C
-Subparagraph (SX 210.12-13C(Column H))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5A
-Subparagraph (SX 210.12-13A(Column E))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5B
-Subparagraph (SX 210.12-13B(Column E))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5B
-Subparagraph (SX 210.12-13B(Column E)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483466/210-20-50-3

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483444/210-20-55-22

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483444/210-20-55-10

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-10

+ Details

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 325,110	$ 270,651	$ 246,246
Cost of Revenue [Abstract]
Cost of Revenue	53,231	50,746	42,557
Gross Profit, Total	271,879	219,905	203,689
Operating Expenses [Abstract]
Research and Development Expense	84,386	80,620	65,541
Selling and Marketing Expense	110,813	97,387	76,389
General and Administrative Expense	43,443	40,854	47,937
Operating Expenses, Total	238,642	218,861	189,867
Operating Income (Loss), Total	33,237	1,044	13,822
Nonoperating Income (Expense)	(108,800)	119,716	68,483
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	(75,563)	120,760	82,305
Income Tax Expense (Benefit)	5,537	(45)	10,909
Net Income (Loss) Attributable to Parent, Total	(81,100)	120,805	71,396
Earnings Per Share [Abstract]
Basic net income (loss) per share attributable to ordinary shareholders	$ (81,100)	$ 116,111	$ 70,433
Basic net income (loss) per ordinary share (in USD per share)	$ (0.43)	$ 0.64	$ 0.49
Diluted net income (loss) per share (in USD per share)	$ (0.43)	$ 0.59	$ 0.44
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)	190,154,549	182,693,375	144,002,394
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)	190,154,549	195,393,558	161,538,579
Subscription Services [Member]
Revenues [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 209,751	$ 153,470	$ 120,889
Cost of Revenue [Abstract]
Cost of Revenue	19,219	16,875	9,369
Term-Licenses [Member]
Revenues [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	70,663	62,487	62,428
Cost of Revenue [Abstract]
Cost of Revenue	6	425	2,299
Professional Services [Member]
Revenues [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	31,135	33,321	28,760
Cost of Revenue [Abstract]
Cost of Revenue	20,240	20,459	21,072
Other non-recurring
Revenues [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	13,561	21,373	34,169
Cost of Revenue [Abstract]
Cost of Revenue	$ 13,766	$ 12,987	$ 9,817

Transactions and Balances with Related Parties (Details) - Related Party - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 345	$ 122
Revenues	$ 4,061	$ 3,586	$ 3,678

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1

+ Details

Summary of Significant Accounting Policies - Schedule of Employee Stock Purchase Plan Assumptions (Details)	12 Months Ended
	Dec. 31, 2023 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	6 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Employee Stock \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate	39.70%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.20%
Share price (in USD per share)	$ 4.69
Employee Stock \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate	50.50%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	5.10%
Share price (in USD per share)	$ 8.42

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480483/718-10-35-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Shareholders’ equity (deficiency) - Schedule of Stock-based Compensation Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	$ 18,998	$ 13,708	$ 6,480
Cost of Sales [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	1,733	1,283	290
Research and Development Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	4,673	2,974	1,076
Selling and Marketing Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	6,478	5,041	2,332
General and Administrative Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	$ 6,114	$ 4,410	$ 2,782

Shareholders’ equity (deficiency) (Tables)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of Stock Option Activity

A summary of the Company’s option activity and related information is as follows:


	Number of options	Weighted- average exercise price		Weighted- average remaining contractual term (in years)
Outstanding at December 31, 2022	20,457,660	$	2.99	6.39
Granted	3,222,786	6.44
Exercised	7,391,891	2.58
Forfeited	560,379	4.67
Outstanding at December 31, 2023	15,728,176	$	3.83	6.23
Exercisable at December 31, 2023	11,441,966	$	3.07	5.25

Schedule of Nonvested Restricted Stock Units Activity

A summary of the Company’s RSUs and PSUs activity is as follows:


			December 31, 2023
			Number of RSUs
Unvested at beginning of year			6,391,352
Granted			5,850,513
Vested			2,216,312
Forfeited			1,865,404
Unvested, at end of year			8,160,149

Summary of Stock-Based Compensation

Share based compensation expenses related to the consolidated statements of operations recognized were comprised as follows:


	Year Ended December 31,
	2023		2022		2021

Cost of revenues	$	1,733	$	1,283	$	290
Research and development	4,673		2,974		1,076
Sales and marketing	6,478		5,041		2,332
General and administrative	6,114		4,410		2,782
	$	18,998	$	13,708	$	6,480

Comprehensive Text Block List

12 Months Ended

Dec. 31, 2023

Text Block [Abstract]

Comprehensive Income (Loss) Note

Note 16. Accumulated other comprehensive income (loss)


	Unrealized Gains (losses) on marketable securities		Unrealized Gains (losses) on cash flow hedges		Foreign currency translation adjustment		Total
Beginning balance	$	(502)	$	(377)	$	1,210	$	331
Other comprehensive income before reclassifications	506		(48)		(1,039)		(581)
Amounts reclassified from accumulated other comprehensive income	—		1,300		—		1,300
Net current period other comprehensive income	506		1,252		(1,039)		719
	$	4	$	875	$	171	$	1,050

Financial income, net

12 Months Ended

Dec. 31, 2023

Nonoperating Income (Expense) [Abstract]

Financial income, net

Note 19. Financial (expense) income, net


	Year Ended December 31,
	2023		2022		2021
Financial income:
Interest on deposits	$	8,888	$	1,603	$	847
Foreign currency translation differences	585		1,736		51
Remeasurement of liability instruments	—		116,863		67,873
Other	1,828		741		276

Financial expenses:
Remeasurement of liability instruments	(119,348)		—		—
Bank charges	(233)		(187)		(166)
Changes in exchange rates	(379)		(891)		(245)
Other	(141)		(149)		(153)
	$	(108,800)	$	119,716	$	68,483

Consolidated Statements of Stockholders' Equity (Deficiency) (Parenthetical)	Aug. 30, 2021
Statement of Stockholders' Equity [Abstract]
Reverse stock split, conversion ratio	0.9595

Summary of Significant Accounting Policies - Goodwill (Details)	12 Months Ended
	Dec. 31, 2023 segment
Accounting Policies [Abstract]
Number of operating segments	1

Transactions and Balances with Related Parties

12 Months Ended

Dec. 31, 2023

Transactions and Balances with Related Parties

Note 20. Transactions and Balances with Related Parties

SUN Corporation, the Company’s controlling shareholder is also a reseller of the Company in the Japanese market.

A.Transactions with SUN Corporation


	Year Ended December 31,
	2023	2022	2021

Revenues	4,061	3,586	3,678

C.Balances with SUN Corporation


	December 31, 2023	December 31, 2022
Trade receivables	345	122

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

+ Details

Shareholders’ equity (deficiency) - Schedule of RSU Activity (Details) - Restricted Stock Units (RSUs)	12 Months Ended
	Dec. 31, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding at beginning of year (in shares)	6,391,352
Granted (in shares)	5,850,513
Vested (in shares)	2,216,312
Forfeited (in shares)	1,865,404
Outstanding at end of year (in shares)	8,160,149

Lease

12 Months Ended

Dec. 31, 2023

Leases [Abstract]

Lease

Note 11. Lease

The Company entered into operating leases primarily for offices. The leases have remaining lease terms of up to 10.5 years

The components of operating lease costs were as follows:


	Year ended December 31, 2023
Operating lease cost	$	4,934
Short-term lease cost	347
Variable lease cost	269
Total net lease costs	$	5,550

Supplemental balance sheet information related to operating leases is as follows:


	Year ended December 31, 2023
Operating lease ROU assets	$	14,260
Operating lease liabilities, current	$	4,972
Operating lease liabilities, long-term	$	9,157
Weighted average remaining lease term (in years)	4.59
Weighted average discount rate	2.48		%

Minimum lease payments for the Company’s ROU assets over the remaining lease periods as of December 31, 2023, are as follows:


Fiscal Years Ending December 31,	Operating Leases
2024	$	5,018
2025	3,939
2026	1,947
2027	1,143
2028 and thereafter	3,442

Total undiscounted lease payments	15,489
Less: imputed interest	(1,360)

Present value of lease liabilities	$	14,129

Derivative Instruments

12 Months Ended

Dec. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Note 10. Derivative Instruments

The Company’s risk management strategy includes the use of derivative financial instruments to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates.

ASC 815, "Derivatives and Hedging" ("ASC 815"), requires the Company to recognize all of its derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, an entity must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation.

Gains and losses on derivatives instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that are attributable to a particular risk), are recorded in accumulated other comprehensive income (loss) and reclassified into statement of income in the same accounting period in which the designated forecasted transaction or hedged item affects earnings.

The Company entered into option and forward contracts to hedge a portion of anticipated New Israeli Shekel ("NIS") payroll and benefit payments. These derivative instruments are designated as cash flow hedges, as defined by ASC 815 and accordingly are measured at fair value. These transactions are effective and, as a result, gain or loss on the derivative instruments are reported as a component of accumulated other comprehensive income and reclassified as Cost of revenues and Operating expenses, at the time that the hedged income/expense is recorded.


	Net Notional amount				Fair value (Level 2 within the fair value hierarchy)
	December 31				December 31,
	2023		2022		2023		2022
Option contracts to hedge payroll
expenses NIS	$	32,158	$	31,833	$	1,159	$	173
Forward contracts to hedge payroll
expenses (income) NIS	—		5,598		—		(229)
	$	32,158	$	37,431	$	1,159	$	(56)

The Company currently hedges its exposure to the variability in future cash flows for a maximum period of one year. As of December 31, 2023, the Company expects to reclassify all of its unrealized gains and losses from accumulated other comprehensive income to earnings during the next nine months. The fair value of the Company's outstanding derivative instruments at December 31, 2023 and 2022 is summarized below:


		Fair value of derivative instruments
		December 31,
	Balance Sheet line item	2023		2022
Derivative liabilities:
Foreign exchange option contracts	Prepaid expenses and other current assets	$	1,159	$	173
Foreign exchange forward contracts	Prepaid expenses and other current assets	—		—
Foreign exchange option contracts	Other account payable	(164)		(596)
Foreign exchange forward contracts	Other account payable	$	—	$	(229)

The effect of derivative instruments in cash flow hedging relationship on income and other comprehensive income for the year ended December 31, 2023, 2022 and 2021, is summarized below:


	Amount of (loss) gain recognized in other comprehensive income on derivative, net of tax (effective portion)
	Year ended December 31,
	2023		2022		2021
Derivatives in foreign exchange cash flow hedging relationships:
Forward contracts	$	(168)	$	(643)	$	110
Option contracts	120		(2,845)		254
	$	(48)	$	(3,488)	$	364

Derivatives in foreign exchange cash flow hedging relationships for the year ended December 31, 2023, 2022 and 2021 , is summarized below:


		Amount of gain (loss) reclassified from other comprehensive income into income (expenses), net of tax (effective portion)
		Year ended December 31,
	Statements of income line item	2023		2022		2021
Option contracts to hedge payroll	Cost of revenues and operating expenses	$	930	$	2,491	$	(657)
Forward contracts to hedge payroll	Cost of revenues and operating expenses	370		44		(651)
		$	1,300	$	2,535	$	(1,308)

Net income (loss) per share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]
Net Income (Loss)	$ (81,100)	$ 120,805	$ 71,396
Net Income (Loss) Available To Restricted Sponsor Stockholders, Basic	0	4,694	963
Net Income (Loss) Available to Common Stockholders, Basic, Total	$ (81,100)	$ 116,111	$ 70,433
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)	190,154,549	182,693,375	144,002,394
Basic net income (loss) per ordinary share (in USD per share)	$ (0.43)	$ 0.64	$ 0.49
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)	190,154,549	195,393,558	161,538,579
Diluted net income (loss) per share (in USD per share)	$ (0.43)	$ 0.59	$ 0.44
Stock Issued During Period, Shares, Employee Stock Ownership Plan	587,579	290,053
Granted (in shares)	3,222,786

Marketable securities - Schedule of Marketable Securities by Contractual Maturities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Marketable Securities [Abstract]
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	$ 38,693	$ 44,643
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Two	28,859	22,125
Debt Securities, Available-for-Sale, Total	$ 67,552	$ 66,768

Intangible assets, net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 3,227
Finite-Lived Intangible Asset, Expected Amortization, Year Two	3,060
Finite-Lived Intangible Asset, Expected Amortization, Year Three	2,543
Finite-Lived Intangible Asset, Expected Amortization, Year Four	1,281
Finite-Lived Intangible Asset, Expected Amortization, After Year Four	483
Intangible assets, net	$ 10,594	$ 11,254

Derivative Instruments - Schedule of Hedges to Payroll Expenses (Details) - Designated as Hedging Instrument - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Derivative, notional amount	$ 32,158	$ 37,431
Foreign Exchange Option [Member]
Derivative [Line Items]
Derivative, notional amount	32,158	31,833
Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, notional amount	0	5,598
Fair Value, Inputs, Level 2
Derivative [Line Items]
Derivative, Fair Value, Net	1,159	(56)
Fair Value, Inputs, Level 2 \| Foreign Exchange Option [Member]
Derivative [Line Items]
Derivative, Fair Value, Net	1,159	173
Fair Value, Inputs, Level 2 \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Fair Value, Net	$ 0	$ (229)

Business combination - Intangible Assets Acquired (Details) - Digital Clues LTD $ in Thousands	Nov. 11, 2021 USD ($)
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 3,524
Technology-Based Intangible Assets [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 3,347
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	7 years
Customer Relationships [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 177
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	10 years

Fair value measurements - Schedule of Level 3 Restricted Sponsor Shares and Price Adjustment Shares (Details) - Level 3 - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Restricted Sponsor Shares [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)	7,500,000	7,500,000
Reverse Recapitalization, Contingent Consideration, Equity, Remaining Exercise Period	4 years 7 months 28 days	5 years 7 months 28 days
Restricted Sponsor Shares [Member] \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	$ 12.5	$ 12.5
Share value (in usd per share)	3.62	1.17
Restricted Sponsor Shares [Member] \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	30.0	30.0
Share value (in usd per share)	$ 7.17	$ 2.63
Price Adjustment Shares [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)	15,000,000	15,000,000
Reverse Recapitalization, Contingent Consideration, Equity, Remaining Exercise Period	2 years 7 months 28 days	3 years 7 months 28 days
Price Adjustment Shares [Member] \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	$ 12.5	$ 12.5
Share value (in usd per share)	4.47	1.32
Price Adjustment Shares [Member] \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	17.5	17.5
Share value (in usd per share)	$ 6.31	$ 2

Cover - shares	12 Months Ended
Cover - shares	Dec. 31, 2023	Mar. 10, 2024
Document Information [Line Items]
Document Type	20-F
Document Registration Statement	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-40772
Entity Registrant Name	Cellebrite DI Ltd.
Entity Incorporation, State or Country Code	L3
Entity Address, Address Line One	94 Shlomo Shmelzer Road
Entity Address, City or Town	Petah Tikva
Entity Address, Postal Zip Code	4970602
Entity Address, Country	IL
Entity Common Stock, Shares Outstanding		205,297,065
Entity Well-Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Accounting Standard	U.S. GAAP
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Central Index Key	0001854587
Document Financial Statement Error Correction [Flag]	false
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Ordinary shares, par value NIS 0.00001
Trading Symbol	CLBT
Security Exchange Name	NASDAQ
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase ordinary shares
Trading Symbol	CLBTW
Security Exchange Name	NASDAQ
Business Contact
Document Information [Line Items]
Entity Address, Address Line One	94 Shlomo Shmelzer Road
Entity Address, City or Town	Petah Tikva
Entity Address, Postal Zip Code	4970602
Entity Address, Country	IL
Contact Personnel Name	Ayala Berler Shapira
Country Region	972
City Area Code	73
Local Phone Number	394-8000

Other accounts payable and accrued expenses (Tables)

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Schedule of Other Accounts Payable and Accrued Expenses


	December 31, 2023		December 31, 2022

Governmental institution	$	2,646	$	1,227
Employees and related expenses	34,111		33,495
Income tax payable	833		2,853
Accrued expenses	6,161		6,244
Advances from customers	862		628
Other	232		1,006
	$	44,845	$	45,453

Consolidated Balance Sheets
$ in Thousands

Dec. 31, 2023

USD ($)

Dec. 31, 2022

USD ($)

Current assets

Marketable securities

$ 38,693

$ 44,643

Trade receivables (net of allowance for credit losses of $1,583 and $1,904 as of December 31, 2023 and December 31, 2022, respectively)

77,269

78,761

Prepaid expenses and other current assets

26,400

17,085

Contract acquisition costs

5,550

6,286

Inventories

9,940

10,176

Total current assets

422,082

295,931

Non-current assets

Other non-current assets

7,341

1,731

Marketable securities

28,859

22,125

Deferred tax assets, net

7,024

12,511

Property and equipment, net

15,896

17,259

Operating Lease, Right-of-Use Asset

14,260

15,653

Intangible assets, net

10,594

11,254

Goodwill

26,829

Total non-current assets

110,803

107,362

Total assets

532,885

403,293

Current liabilities

Trade payables

8,282

4,612

Other accounts payable and accrued expenses

44,845

45,453

Deferred revenues

195,725

152,709

Operating lease liabilities

4,972

5,003

Total current liabilities

253,824

207,777

Long-term liabilities

Other long term liabilities

5,515

5,394

Operating lease liabilities

9,157

10,353

Deferred revenues

47,098

42,173

Restricted Sponsor Shares liability

47,247

17,532

Price Adjustment Shares liability

81,715

26,184

Warrant liability

54,117

20,015

Total long-term liabilities

244,849

121,651

Total liabilities

498,673

329,428

Commitments and contingencies

Equity [Abstract]

Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized and 203,230,928 and 193,014,155 shares issued and outstanding as of December 31, 2023 and 2022, respectively

^[1]

Additional paid-in capital

(84,896)

(125,624)

Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares

(85)

Accumulated Other Comprehensive Income (Loss), Net of Tax

1,050

331

Retained earnings

118,143

199,243

Total Shareholders’ equity

34,212

73,865

Total liabilities and shareholders’ equity

532,885

403,293

Cash and Cash Equivalents, at Carrying Value

189,517

87,645

Deposits Assets, Current

$ 74,713

$ 51,335

[1]	Less than US$ 1.

Fair value measurements (Tables)

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Change in Fair Value


	Public Warrants (Level 1)		Private Placement Warrants (Level 3)		Total Warrant liability
Balance, December 31, 2021	$	35,200	$	21,278	$	56,478
Change in fair value	(22,240)		(14,223)		(36,463)
Balance, December 31, 2022	$	12,960	$	7,055	$	20,015
Change in fair value	18,439		15,663		34,102
Balance, December 31, 2023	$	31,399	$	22,718	$	54,117


	Restricted sponsor shares (level 3)		Price adjustment shares (level 3)		Total
Balance, December 31, 2021	$	44,712	$	79,404	$	124,116
Change in fair value of restricted sponsor shares and price adjustment shares	(27,180)		(53,220)		(80,400)
Balance, December 31, 2022	$	17,532	$	26,184	$	43,716
Change in fair value of restricted sponsor shares and price adjustment shares	29,715		55,531		85,246
Balance, December 31, 2023	$	47,247	$	81,715	$	128,962

Schedule of Level 3 Fair Value Measurement Inputs

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2023	December 31, 2022
Number of private placement warrants	9,666,667	9,666,667
Exercise price	$11.5	$11.5
Share price	$8.66	$4.36
Expiration term (in years)	2.66	3.66
Volatility	51.9%	52.9%
Risk-free Rate	4.10%	4.13%
Dividend yield	0%	0%

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2023		December 31, 2022
	Restricted sponsor shares	Price adjustment shares	Restricted sponsor shares	Price adjustment shares
Number of shares	7,500,000	15,000,000	7,500,000	15,000,000
Share price	$12.5-$30.0	$12.5-$17.5	$12.5-$30.0	$12.5-$17.5
Remaining exercise period	4.66	2.66	5.66	3.66
Share value	$3.62-$7.17	$4.47-$6.31	$1.17-$2.63	$1.32-$2

Consolidated Balance Sheets (Parenthetical)
$ in Thousands

Dec. 31, 2023

USD ($)

Dec. 31, 2022

USD ($)

Statement of Financial Position [Abstract]

Trade receivable, allowance for credit loss | $

$ 1,583

$ 1,904

Common stock, shares authorized (in shares)

3,454,112,863

Common stock, shares issued (in shares)

^[1]

203,230,928

Common stock shares outstanding (in shares)

193,014,155

Treasury Stock, Common, Shares

41,776

[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 13, Shareholders’ equity (deficiency), for details.

Taxes on income - Schedule of Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Taxes Payable, Current [Abstract]
Current Federal Tax Expense (Benefit)	$ 3,010	$ (2,573)	$ 9,665
Current Foreign Tax Expense (Benefit)	(2,876)	4,920	2,882
Current Income Tax Expense (Benefit), Total	134	2,347	12,547
Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]
Deferred Federal Income Tax Expense (Benefit)	1,596	(85)	(10)
Deferred Foreign Income Tax Expense (Benefit)	3,807	(2,307)	(1,628)
Deferred Income Tax Expense (Benefit), Total	5,403	(2,392)	(1,638)
Income Tax Expense (Benefit), Total	$ 5,537	$ (45)	$ 10,909
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	23.00%	23.00%	23.00%

Prepaid expenses and other current assets - Schedule of Prepayments and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]
Prepayments To Suppliers, Current	$ 598	$ 790
Prepaid Expense, Current	8,894	7,807
Value Added Tax Receivable, Current	15,470	7,401
Other Assets, Miscellaneous, Current	1,438	1,087
Prepaid Expense and Other Assets, Current	$ 26,400	$ 17,085

Lease - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating Lease, Right-of-Use Asset	$ 14,260	$ 15,653
Operating Lease, Liability, Current	4,972	5,003
Operating Lease, Liability, Noncurrent	$ 9,157	$ 10,353
Operating Lease, Weighted Average Remaining Lease Term	4 years 7 months 2 days
Operating Lease, Weighted Average Discount Rate, Percent	2.48%

General (Details) $ / shares in Units, $ in Thousands			12 Months Ended
General (Details) $ / shares in Units, $ in Thousands	Nov. 11, 2021 USD ($)	Aug. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2023 ₪ / shares	Dec. 31, 2022 ₪ / shares
Business Acquisition [Line Items]
Payments of Dividends			$ 0	$ 0	$ 100,000
Common stock par value per share (in USD per share) \| (per share)		$ 10				₪ 0.00001	₪ 0.00001
PIPE Investor, Share Purchase Agreement
Business Acquisition [Line Items]
Sale of stock, price per share (in USD per share) \| $ / shares		$ 10.00
Number of shares issued in transaction (in shares) \| shares		30,000,000
Sale of stock, consideration received		$ 300,000
Conversion of stock, shares converted (in shares) \| shares		30,000,000
Initial dividend paid
Business Acquisition [Line Items]
Payments of Dividends		$ 21,300
Additional dividend paid
Business Acquisition [Line Items]
Payments of Dividends		$ 78,700
Digital Clues (“DC”)
Business Acquisition [Line Items]
Total consideration transferred	$ 20,000
TWC Tech Holdings II Corp. (“TWC") \| TWC Securityholders
Business Acquisition [Line Items]
Recapitalization exchange ratio (in shares) \| shares		1

Marketable securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Marketable Securities [Line Items]
Amortized cost	$ 67,546	$ 67,459
Gross unrealized gains	133	8
Gross unrealized losses	(127)	(699)
Fair value (Level 2)	67,552	66,768
Corporate bond
Marketable Securities [Line Items]
Amortized cost	18,521	20,963
Gross unrealized gains	57	0
Gross unrealized losses	(29)	(266)
Fair value (Level 2)	18,549	20,697
Agency bond
Marketable Securities [Line Items]
Amortized cost	40,487	24,394
Gross unrealized gains	63	8
Gross unrealized losses	(64)	(237)
Fair value (Level 2)	40,486	24,165
Treasury bills
Marketable Securities [Line Items]
Amortized cost		7,126
Gross unrealized gains		0
Gross unrealized losses		(9)
Fair value (Level 2)		7,117
US Government
Marketable Securities [Line Items]
Amortized cost	8,538	10,005
Gross unrealized gains	13	0
Gross unrealized losses	(34)	(187)
Fair value (Level 2)	$ 8,517	9,818
Municipality
Marketable Securities [Line Items]
Amortized cost		175
Gross unrealized gains		0
Gross unrealized losses		0
Fair value (Level 2)		175
Commercial paper
Marketable Securities [Line Items]
Amortized cost		4,796
Gross unrealized gains		0
Gross unrealized losses		0
Fair value (Level 2)		$ 4,796

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

A.Basis of presentation

The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP).

B.Financial statements in United States dollars

C.Use of estimates

D.Principles of consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation.

E.Cash and cash equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents.

F. Short Term Bank Deposit

Short-term bank deposits consist of bank deposits with original maturities of more than three months and up to twelve months.

G. Marketable securities

H. Trade Receivable

Trade receivables are recorded net of credit losses allowance for any potential uncollectible amounts.

As of December 31, 2023 and 2022, the allowances for credit losses of trade receivable were $1,583 and $1,904 respectively.

I. Inventories

J. Property and equipment


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.

K. Impairment of long-lived assets

During the year ended December 31, 2023, 2022 and 2021, no impairment losses have been identified.

L. Leases

The Company determines if an arrangement meets the definition of a lease at the inception of the lease.

M. Revenue recognition

The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users.

Other non-recurring revenue derived mostly from hardware sold mainly in conjunction with new software license, perpetual license and usage-based fees.

N. Contract acquisition cost

Amortization of deferred contract acquisition cost for the year ended December 31, 2023, 2022 and 2021 were $9,596, $6,883 and $5,405 respectively.

Assets recognized from the costs incurred to obtain a contract were $6,245 and $6,846 as of December 31, 2023 and 2022, respectively.

O. Research and development

P. Internal use software

Q. Employee benefit plans

As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company's balance sheet.

For the year ended December 31, 2023, 2022 and 2021 severance pay expenses amounted to $4,305, $4,392 and $4,067 respectively.

R. Advertising Expenses

Marketing events expenses and other related marketing expenses are charged to expense as incurred. Marketing expenses for the years 2023, 2022 and 2021 were $7,853, $5,906 and $5,274 respectively.

S. Income taxes

T. Stock-Based Compensation

The Company grants awards that vest upon the satisfaction of service condition and in certain grant market conditions.

The Company estimate the fair value of share options granted using the Black-Scholes-Merton option-pricing model and for ESPP awards Monte Carlo pricing model and acceleration method.

The Company used the following weighted-average assumptions for options granted to employees and non-employees:


	Year ended December 31,
	2023	2022	2021
Contractual period in years	10	10	10
Volatility	50.3% - 51.8%	43.2% - 51.9%	35.9% - 52.7%
Risk free interest rate	3.7% - 4.5%	2.0% - 4.2%	1.3% - 1.4%
Dividend yield	0%	0%	0% - 5%
Exercise price	$4.95 - $7.99	$4.79 - $6.60	$5.41 - $8.27
Fair value of Ordinary Share	$4.95 - $7.99	$4.79 - $6.60	$5.41 - $8.27
Expected term	6.11	6.11	6.11

The fair value of ESPP was estimated on the grant date using Monte Carlo valuation methodology with the following weighted average assumptions:


						Year Ended December 31,
						2023

Volatility						39.7%-50.5%
Expected term						6 months
Risk-free interest rate						4.2%-5.1%
Share price						$4.69-$8.42
Dividend yield						0%

These assumptions and estimates were determined as follows:

Expected Volatility ESPP — was based on Cellebrite’s historical share price volatility, on a daily basis, for 6 months.

Expected dividend yield— The Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield.

U. Fair value measurements

• Level 1: Quoted prices in active markets for identical assets or liabilities.

• Level 2: Inputs other than Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

V. Derivative instruments

The fair value of derivative instruments liabilities and assets balances as of December 31, 2023 and 2022, totaled $995 and $652, respectively.

W. Goodwill

X. Intangible assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Y. Business combination

Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred.\

Z. Concentrations of credit risk

AA. Segment information

Revenue by geographical region can be found in the revenue recognition disclosures in Note 17 below. The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets:


	December 31,
		2023		2022

EMEA		$	20,691	$	26,595
Americas		8,024		5,712
APAC		1,441		605
Total long-lived assets		$	30,156	$	32,912

AB. Basic and diluted net (loss) income per share

AC. Recently issued accounting pronouncements

Recently adopted accounting pronouncements:

The adoption did not have a material impact on the Company’s consolidated financial statements.

Recently issued accounting pronouncements not yet adopted:

Taxes on income - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Oct. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Investments, Owned, Federal Income Tax Note [Line Items]
Decrease in provision for tax on trapped earnings due to utilization in period	$ 4,900		$ 71
Increase in provision for tax on trapped earnings due to additional provision recognized			7
Undistributed earnings of foreign subsidiaries		$ 45,431
Interest on income taxes accrued		$ 470	$ 297
Approved Enterprise and Beneficiary Enterprise \| Minimum
Investments, Owned, Federal Income Tax Note [Line Items]
Beneficial tax rate		0.00%
Approved Enterprise and Beneficiary Enterprise \| Maximum
Investments, Owned, Federal Income Tax Note [Line Items]
Beneficial tax rate		10.00%

Summary of Significant Accounting Policies - Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2023
Computer Equipment [Member] \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	12.50%
Computer Equipment [Member] \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	33.00%
Other Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7.00%
Office Equipment [Member] \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	7.00%
Office Equipment [Member] \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	15.00%

Business combination - Narrative (Details) $ / shares in Units, $ in Thousands			12 Months Ended
	Nov. 11, 2021 USD ($)	Aug. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2023 ₪ / shares	Dec. 31, 2022 ₪ / shares
Business Acquisition [Line Items]
Goodwill			$ 26,829	$ 26,829
Amortization expense			3,347	2,826	$ 1,971
Payments of Dividends			0	0	100,000
Common stock par value per share (in USD per share) \| (per share)		$ 10				₪ 0.00001	₪ 0.00001
PIPE Investor, Share Purchase Agreement
Business Acquisition [Line Items]
Sale of stock, price per share (in USD per share) \| $ / shares		$ 10.00
Number of shares issued in transaction (in shares) \| shares		30,000,000
Sale of stock, consideration received		$ 300,000
Conversion of stock, shares converted (in shares) \| shares		30,000,000
Initial dividend paid
Business Acquisition [Line Items]
Payments of Dividends		$ 21,300
Additional dividend paid
Business Acquisition [Line Items]
Payments of Dividends		$ 78,700
TWC Tech Holdings II Corp. (“TWC") \| TWC Securityholders
Business Acquisition [Line Items]
Recapitalization exchange ratio (in shares) \| shares		1
Digital Clues LTD
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 3,524
Goodwill	17,366
Amortization expense			$ 496	$ 496	$ 67
Total consideration transferred	20,000
Digital Clues LTD \| Technology-Based Intangible Assets [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 3,347
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	7 years

Lease - Schedule of Future Minimum Rental Payments (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Leases [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One	$ 5,018
Lessee, Operating Lease, Liability, to be Paid, Year Two	3,939
Lessee, Operating Lease, Liability, to be Paid, Year Three	1,947
Lessee, Operating Lease, Liability, to be Paid, Year Four	1,143
Lessee, Operating Lease, Liability, To Be Paid, After Year Four	3,442
Lessee, Operating Lease, Liability, to be Paid, Total	15,489
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(1,360)
Operating Lease, Liability	$ 14,129

Prepaid expenses and other current assets

12 Months Ended

Dec. 31, 2023

Prepaid Expense and Other Assets, Current [Abstract]

Prepaid expenses and other current assets

Note 6. Prepaid expenses and other current assets


	December 31, 2023		December 31, 2022

Advances to suppliers	$	598	$	790
Prepaid expenses	8,894		7,807
Government institutions	15,470		7,401
Other	1,438		1,087
	$	26,400	$	17,085

Summary of Significant Accounting Policies - Marketing Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Marketing expense	$ 7,853	$ 5,906	$ 5,274

Summary of Significant Accounting Policies - Intangible Assets (Details)	Dec. 31, 2023
Technology-Based Intangible Assets [Member] \| Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	4 years
Technology-Based Intangible Assets [Member] \| Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	7 years
Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	4 years
Customer Relationships [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	10 years

Revenues

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenues

Note 17. Revenues

Disaggregation of Revenues

The following table provides information about disaggregated revenue by geographical areas


	Year Ended December 31,
	2023		2022		2021

EMEA	$	112,247	$	92,749	$	88,441
America	172,154		141,920		126,929
APAC	40,709		35,982		30,876
Total	$	325,110	$	270,651	$	246,246

Contract Balances

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:


	December 31, 2023		December 31, 2022
Contract liabilities, current	$	195,725	$	152,709
Contract liabilities, non-current	47,098		42,173

Unbilled receivables include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. The increase in contract balances is consistent with the increase in the overall operation of the Company.

Contract liabilities consist of deferred revenue. Revenue is deferred when the Company invoices in advance of performance under a contract. The current portion of the deferred revenue balance is recognized as revenue during the 12-month period after the balance sheet date. The non current portion of the deferred revenue balance is recognized as revenue following the 12-month period after the balance sheet date. Of the $194,882 and $159,409 of deferred revenue as of December 31, 2022 and December 31, 2021, respectively, the Company recognized $141,307 and $104,868 as revenue during the year ended December 31, 2023 and 2022, respectively.

Remaining Performance Obligations

The Company’s remaining performance obligations are comprised of product and services revenue not yet delivered. As of December 31, 2023 and December 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $331,996 and $276,409 respectively, which consists of both billed consideration in the amount of $242,823 and $194,882 respectively, and unbilled consideration in the amount of $89,173 and $81,527 respectively, that the Company expects to recognize as revenue. As of December 31, 2023, the Company expects to recognize the majority of its remaining performance obligations as revenue in the year ended December 31, 2023.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org//606/tableOfContent

+ Details

Derivative Instruments - Schedule of Foreign Exchange Cash Flow Hedges (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Foreign Currency Fair Value Hedge Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	$ 1,300	$ 2,535	$ (1,308)
Cost of revenues and operating expenses \| Foreign Exchange Option [Member]
Foreign Currency Fair Value Hedge Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	930	2,491	(657)
Cost Of Revenues, Operating Expenses, And Financial Expenses [Member] \| Foreign Exchange Forward [Member]
Foreign Currency Fair Value Hedge Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	$ 370	$ 44	$ (651)

Inventories (Tables)

12 Months Ended

Dec. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventory


	December 31, 2023		December 31, 2022

Raw materials	$	7,815	$	7,451
Finished goods	2,125		2,725
	$	9,940	$	10,176

Derivative Instruments - Schedule of Derivative Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Prepaid Expenses and Other Current Assets [Member] \| Foreign Exchange Option [Member]
Derivative [Line Items]
Derivative Asset, Subject to Master Netting Arrangement, before Offset	$ 1,159	$ 173
Prepaid Expenses and Other Current Assets [Member] \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative Asset, Subject to Master Netting Arrangement, before Offset	0	0
Accounts Payable [Member] \| Foreign Exchange Option [Member]
Derivative [Line Items]
Derivative Liability, Not Subject to Master Netting Arrangement	(164)	(596)
Accounts Payable [Member] \| Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative Liability, Not Subject to Master Netting Arrangement	$ 0	$ (229)

Business combination

12 Months Ended

Dec. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Business combination

Note 3. Business combination

Acquisition of Digital Clues Carved Out Assets:

On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets (“DC Assets”), for a total consideration of $20,000 . The DC Assets provide the ability to view, collect, and analyze information from on-line open sources, and produce actionable intelligence. The asset acquisition meets the definition of a business.

The purchase price allocation for the acquisition has been determined as follows:


	Amount
Net assets	$	(890)
Technology	3,347
Customer relationship	177
Goodwill	17,366
Total	$	20,000

Goodwill is primarily attributable to expected synergies arising from technology integration and expanded product availability to the Company’s existing and new customers. Goodwill is deductible for income tax purpose.

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition:


	Fair Value		Useful Life
	US$ thousands		In years
Core technology	3,347		7
Customer relationship	177		10
Total identifiable intangible assets	$	3,524

During the years ended December 31, 2023 , 2022 and 2021, the Company recorded amortization expenses of $496, $496 and $67, respectively.

Intangible assets, net

12 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets, net

Note 4. Intangible assets, net

Finite-lived intangible assets:


	December 31, 2023		December 31, 2022


Original amounts:
Core technology	$	15,950	$	13,263
Trade name	3,900		3,900
Customer relationship	177		177
	20,027		17,340
Accumulated amortization:
Core technology	5,657		3,303
Trade name	3,738		2,763
Customer relationship	38		20
	9,433		6,086
Intangible assets, net
	$	10,594	$	11,254

a. Amortization expense amounted to $3,347, $2,826 and $1,971 for the years ended December 31, 2023, 2022 and 2021, respectively.

b. The expected future amortization expenses by year related to the intangible assets as of December 31, 2023 are as follows:




2024	$	3,227
2025	3,060
2026	2,543
2027	1,281
2028 and thereafter	483
	$	10,594

Taxes on income - Schedule of Income Tax Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income before income taxes expense, as reported in the consolidated statements of operations	$ (75,563)	$ 120,760	$ 82,305
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	23.00%	23.00%	23.00%
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	$ (17,379)	$ 27,775	$ 18,930
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	565	104	167
Effective Income Tax Rate Reconciliation, Preferred Tax Rate, Amount	9,713	(12,121)	(7,598)
Effective Income Tax Rate Reconciliation, Gain (Loss) On Revaluation Of Liability Instruments, Amount	14,322	(14,024)	(8,145)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount	823	400	1,363
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount	(1,193)	103	(125)
Effective Income Tax Rate Reconciliation, Tax Rate Differential For Dividend Distributed From Approved Enterprise Status	0	(2,369)	7,068
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	(2,087)	0	0
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	773	87	(751)
Income Tax Expense (Benefit), Total	$ 5,537	$ (45)	$ 10,909

Taxes on income - Schedule of Income Before Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income (Loss) from Continuing Operations before Income Taxes, Domestic	$ (88,298)	$ 110,187	$ 71,434
Income (Loss) from Continuing Operations before Income Taxes, Foreign	12,735	10,573	10,871
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	$ (75,563)	$ 120,760	$ 82,305

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-SubTopic 20
-Topic 940
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481913/940-20-25-1

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

+ Details

Commitments and contingencies	12 Months Ended
Commitments and contingencies	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Note 12. Commitments and contingencies From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated the Company would accrue a liability for the estimated loss. As of December 31, 2023 and 2022, the Company is not involved in any claims or legal proceedings which require accrual of liability for the estimated loss.

Comprehensive Text Block List (Tables)

12 Months Ended

Dec. 31, 2023

Text Block [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)


	Unrealized Gains (losses) on marketable securities		Unrealized Gains (losses) on cash flow hedges		Foreign currency translation adjustment		Total
Beginning balance	$	(502)	$	(377)	$	1,210	$	331
Other comprehensive income before reclassifications	506		(48)		(1,039)		(581)
Amounts reclassified from accumulated other comprehensive income	—		1,300		—		1,300
Net current period other comprehensive income	506		1,252		(1,039)		719
	$	4	$	875	$	171	$	1,050

Revenues - Schedule of Disaggregation of Revenues (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 325,110	$ 270,651	$ 246,246
EMEA [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	112,247	92,749	88,441
Americas [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	172,154	141,920	126,929
Asia Pacific [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 40,709	$ 35,982	$ 30,876

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-4

+ Details

Summary of Significant Accounting Policies - Recently Issued Accounting Pronouncements (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Accounts Receivable, Allowance for Credit Loss	$ 1,583	$ 1,904
Operating Lease, Right-of-Use Asset	14,260	$ 15,653
Operating Lease, Liability	$ 14,129

Fair value measurements

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Fair value measurements

Note 15. Fair value measurements

Warrant liability

Upon the closing of the transaction, 20,000,000 Public Warrants and 9,666,667 private warrants, that were both issued by TWC prior to the transaction, were outstanding to purchase the Company’s Ordinary Shares. Each warrant entitles the holder to purchase one Company Ordinary Share at a price of $11.50 per share, subject to adjustments. The warrants are exercisable at any time commencing 30 days after the completion of the transaction and expire five years after the Closing Date or earlier upon redemption or liquidation. The Company may redeem the outstanding Public Warrants in whole and not in part at a price of $0.01 per warrant at any time after they become exercisable, provided that the last sale price of the Company Ordinary Shares equals or exceeds $18 per share, subject to adjustments, for any 20 trading-days within a 30 trading-day period ending three business days prior to the date on which the Company sends the notice of redemption to the warrant holders.

The private warrants have similar terms as the Public Warrants, except that the private warrants may be exercised for cash or on a cashless basis at the holder’s option and the private warrants will not be redeemed by the Company as long as they are held by the initial purchasers or their permitted transferees, but once they are transferred, they have the same rights as the Public Warrants.

The Company has classified the warrants assumed during the Merger (both public and private) as a liability pursuant to ASC 815-40 since the warrants do not meet the equity classification conditions. Accordingly, the Company measured the warrants at their fair value. The warrants liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of comprehensive loss.

During the year ended December 31, 2022, 500 public warrants were exercised in a total amount of $5.


	Public Warrants (Level 1)		Private Placement Warrants (Level 3)		Total Warrant liability
Balance, December 31, 2021	$	35,200	$	21,278	$	56,478
Change in fair value	(22,240)		(14,223)		(36,463)
Balance, December 31, 2022	$	12,960	$	7,055	$	20,015
Change in fair value	18,439		15,663		34,102
Balance, December 31, 2023	$	31,399	$	22,718	$	54,117

The estimated fair value of the private placement warrant liabilities is determined using Level 3 inputs. Inherent in a Black-Scholes valuation model are assumptions related to expected share-price volatility, expiration, risk-free interest rate and dividend yield. The Company estimates the volatility of its common share based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates will remain at 0%.

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2023	December 31, 2022
Number of private placement warrants	9,666,667	9,666,667
Exercise price	$11.5	$11.5
Share price	$8.66	$4.36
Expiration term (in years)	2.66	3.66
Volatility	51.9%	52.9%
Risk-free Rate	4.10%	4.13%
Dividend yield	0%	0%

Restricted sponsor shares liability and Price adjustment shares liability

7,500,000 Ordinary Shares issued to TWC Tech Holdings II, LLC, out of a total of 13,500,000 shares, are Restricted Sponsor Shares and will vest in 3 tranches of 3,000,000, 3,000,000 and 1,500,000, upon achievement of the triggering events (as defined in the Business Combination Agreement)); if at any time during the Price Adjustment Period the price of Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period. In the event of a post-Closing change of control transaction involving the Company, any Restricted Sponsor Shares not previously vested will vest and will be entitled to participate in the change of control transaction. The probability of such event was considered by the Company. Upon the expiration of the Price Adjustment Period (a period of seven years), any unvested Cellebrite Shares that have not vested as of such time will be forfeited. The Company security holders shall be entitled to vote their unvested Restricted Sponsor Shares and receive dividends and other distribution, and to have all other economic rights, in each case, with respect to such Restricted Sponsor Shares while they remain unvested.

Holders of the Ordinary Shares and vested RSUs, in each case as of immediately prior to the Effective Time, are eligible to receive up to 15,000,000 Ordinary Shares that will vest in 3 tranches of 5,000,000 upon achievement of the triggering events (if at any time during the Price Adjustment Period the price of Ordinary Shares will be greater than or equal to $12.50, $15.00 and $17.50, respectively, over any 20 trading-days within any 30 trading-day period.) or upon a Change of Control (as defined in Merger Agreement) before the five (5) year anniversary of the Closing Date.

The restricted Sponsor shares liability and Price adjustment shares are measured at fair value using Level 3 inputs.

The Company has determined that the price adjustment shares, and the restricted sponsor shares are freestanding financing instruments since those rights are legally detachable and separately exercisable. The Company has determined that the price adjustment rights, and the restricted sponsor shares are not indexed to Company’s stock since if a change of control occurs, all the shares underlying the price adjustment shares and the restricted sponsor shares will be issued regardless of the company’s stock price. Therefore, the Company accounted for the price adjustment shares and for the restricted sponsor shares as a liability measured at fair value through earnings.


	Restricted sponsor shares (level 3)		Price adjustment shares (level 3)		Total
Balance, December 31, 2021	$	44,712	$	79,404	$	124,116
Change in fair value of restricted sponsor shares and price adjustment shares	(27,180)		(53,220)		(80,400)
Balance, December 31, 2022	$	17,532	$	26,184	$	43,716
Change in fair value of restricted sponsor shares and price adjustment shares	29,715		55,531		85,246
Balance, December 31, 2023	$	47,247	$	81,715	$	128,962

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2023		December 31, 2022
	Restricted sponsor shares	Price adjustment shares	Restricted sponsor shares	Price adjustment shares
Number of shares	7,500,000	15,000,000	7,500,000	15,000,000
Share price	$12.5-$30.0	$12.5-$17.5	$12.5-$30.0	$12.5-$17.5
Remaining exercise period	4.66	2.66	5.66	3.66
Share value	$3.62-$7.17	$4.47-$6.31	$1.17-$2.63	$1.32-$2

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Lease (Tables)

12 Months Ended

Dec. 31, 2023

Leases [Abstract]

Summary of Components of Operating Lease Cost

The components of operating lease costs were as follows:


	Year ended December 31, 2023
Operating lease cost	$	4,934
Short-term lease cost	347
Variable lease cost	269
Total net lease costs	$	5,550

Schedule of Supplemental Balance Sheet Information Related to Operating Leases

Supplemental balance sheet information related to operating leases is as follows:


	Year ended December 31, 2023
Operating lease ROU assets	$	14,260
Operating lease liabilities, current	$	4,972
Operating lease liabilities, long-term	$	9,157
Weighted average remaining lease term (in years)	4.59
Weighted average discount rate	2.48		%

Lessee, Operating Lease, Liability, Maturity

Minimum lease payments for the Company’s ROU assets over the remaining lease periods as of December 31, 2023, are as follows:


Fiscal Years Ending December 31,	Operating Leases
2024	$	5,018
2025	3,939
2026	1,947
2027	1,143
2028 and thereafter	3,442

Total undiscounted lease payments	15,489
Less: imputed interest	(1,360)

Present value of lease liabilities	$	14,129

Marketable securities (Tables)

12 Months Ended

Dec. 31, 2023

Marketable Securities [Abstract]

Summary of Marketable Securities

Marketable securities consisted of the following:


	December 31, 2023
	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value (Level 2)

Corporate bond	$	18,521	$	57	$	(29)	$	18,549
Agency bond	40,487		63		(64)		40,486

US Government	8,538		13		(34)		8,517


Total	$	67,546	$	133	$	(127)	$	67,552


	December 31, 2022
	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value

Corporate bond	$	20,963	$	—	$	(266)	$	20,697
Agency bond	24,394		8		(237)		24,165
Treasury bills	7,126		—		(9)		7,117
US Government	10,005		—		(187)		9,818
Municipality	175		—		—		175
Commercial paper	4,796		—		—		4,796
Total	$	67,459	$	8	$	(699)	$	66,768

As of December 31, 2023 and 2022, no continuous unrealized losses for 12 months or greater were identified.

The following table summarizes the Company’s marketable securities by contractual maturities:


	December 31, 2023		December 31, 2022

Due in 1 year or less	$	38,693	$	44,643
Due in 1 year through 2 years	28,859		22,125
Total	$	67,552	$	66,768

Property and equipment, net (Tables)

12 Months Ended

Dec. 31, 2023

Property, Plant and Equipment [Abstract]

Property and Equipment

Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.


	December 31, 2023		December 31, 2022

Manufacturing equipment	$	582	$	546
Furniture and equipment	10,461		10,203
Leasehold improvements	7,465		6,674
Computers and software	30,641		27,140
	49,149		44,563

Less—accumulated depreciation	(33,253)		(27,304)
	$	15,896	$	17,259

Taxes on income - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred Tax Assets, Gross [Abstract]
Deferred Tax Assets, Tax Deferred Expense, Other	$ 2,661	$ 4,410
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation	3,275	2,023
Deferred Tax Asset, Intangible Assets	857	991
Deferred Tax Assets, Goodwill	1,647	2,851
Deferred Tax Assets, Deferred Income	2,563	2,167
Deferred Tax Assets, Operating Loss Carryforwards	0	1,826
Deferred Tax Assets, Operating Lease Liability	2,732	2,094
Deferred Tax Assets, Issuance Costs	0	675
Deferred Tax Assets, Investments	13	189
Deferred Tax Assets, Derivative Instruments	0	52
Deferred Tax Assets, Property, Plant and Equipment	39	0
Deferred Tax Assets, Other	749	765
Deferred Tax Assets, Gross, Total	14,536	18,043
Deferred Tax Liabilities, Gross [Abstract]
Deferred Tax Liabilities, Deferred Expense	3,066	1,946
Deferred Tax Liability, Intangible Assets	337	497
Deferred Tax Liability, Goodwill	445	237
Deferred Tax Liabilities, Property, Plant and Equipment	874	777
Deferred Tax Liabilities, Leasing Arrangements	2,652	2,022
Deferred Tax Liabilities, Derivatives	119	0
Deferred Tax Liabilities, Other	4	53
Deferred Tax Liabilities, Gross, Total	7,512	5,532
Deferred Tax Assets, Net, Total	7,024	12,511
Deferred Tax Liabilities, Investments	$ 15	$ 0

Marketable securities

12 Months Ended

Dec. 31, 2023

Marketable Securities [Abstract]

Marketable securities

Note 5. Marketable securities

Marketable securities consisted of the following:


	December 31, 2023
	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value (Level 2)

Corporate bond	$	18,521	$	57	$	(29)	$	18,549
Agency bond	40,487		63		(64)		40,486

US Government	8,538		13		(34)		8,517


Total	$	67,546	$	133	$	(127)	$	67,552


	December 31, 2022
	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value

Corporate bond	$	20,963	$	—	$	(266)	$	20,697
Agency bond	24,394		8		(237)		24,165
Treasury bills	7,126		—		(9)		7,117
US Government	10,005		—		(187)		9,818
Municipality	175		—		—		175
Commercial paper	4,796		—		—		4,796
Total	$	67,459	$	8	$	(699)	$	66,768

As of December 31, 2023 and 2022, no continuous unrealized losses for 12 months or greater were identified.

The following table summarizes the Company’s marketable securities by contractual maturities:


	December 31, 2023		December 31, 2022

Due in 1 year or less	$	38,693	$	44,643
Due in 1 year through 2 years	28,859		22,125
Total	$	67,552	$	66,768